well-20240630
0000766704false2024Q2December 31P1Yhttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#LeaseRightOfUseAssethttp://www.welltower.com/20240630#ReceivablesAndOtherAssetshttp://www.welltower.com/20240630#ReceivablesAndOtherAssetshttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityhttp://www.welltower.com/20240630#LeaseLiabilityP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewell:propertywell:joint_venturewell:projectwell:loanwell:propertieswell:partnerwell:bankiso4217:CADwell:Termwell:termiso4217:GBPwell:obligationwell:segment00007667042024-01-012024-06-300000766704us-gaap:CommonStockMember2024-01-012024-06-300000766704well:GuaranteeNotesDue20284800Member2024-01-012024-06-300000766704well:GuaranteeNotesDue20344500Member2024-01-012024-06-3000007667042024-07-2600007667042024-06-3000007667042023-12-3100007667042024-04-012024-06-3000007667042023-04-012023-06-3000007667042023-01-012023-06-300000766704us-gaap:CommonStockMember2023-12-310000766704us-gaap:AdditionalPaidInCapitalMember2023-12-310000766704us-gaap:TreasuryStockCommonMember2023-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-12-310000766704well:AccumulatedDistributionsMember2023-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000766704us-gaap:NoncontrollingInterestMember2023-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-01-012024-03-310000766704us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100007667042024-01-012024-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000766704us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000766704us-gaap:CommonStockMember2024-01-012024-03-310000766704us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000766704well:AccumulatedDistributionsMember2024-01-012024-03-310000766704us-gaap:CommonStockMember2024-03-310000766704us-gaap:AdditionalPaidInCapitalMember2024-03-310000766704us-gaap:TreasuryStockCommonMember2024-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-03-310000766704well:AccumulatedDistributionsMember2024-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000766704us-gaap:NoncontrollingInterestMember2024-03-3100007667042024-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2024-04-012024-06-300000766704us-gaap:NoncontrollingInterestMember2024-04-012024-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000766704us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000766704us-gaap:CommonStockMember2024-04-012024-06-300000766704us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000766704well:AccumulatedDistributionsMember2024-04-012024-06-300000766704us-gaap:CommonStockMember2024-06-300000766704us-gaap:AdditionalPaidInCapitalMember2024-06-300000766704us-gaap:TreasuryStockCommonMember2024-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2024-06-300000766704well:AccumulatedDistributionsMember2024-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000766704us-gaap:NoncontrollingInterestMember2024-06-300000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-3100007667042022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100007667042023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-3100007667042023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-04-012023-06-300000766704us-gaap:NoncontrollingInterestMember2023-04-012023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-04-012023-06-300000766704us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000766704well:AccumulatedDistributionsMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-06-300000766704us-gaap:TreasuryStockCommonMember2023-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2023-06-300000766704well:AccumulatedDistributionsMember2023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000766704us-gaap:NoncontrollingInterestMember2023-06-3000007667042023-06-300000766704well:WelltowerOPIncMember2024-01-012024-06-300000766704well:WelltowerOPIncMember2024-06-300000766704well:OtherInvestorsMemberwell:WelltowerOPIncMember2024-06-300000766704well:SeniorHousingOperatingMember2024-06-300000766704well:TripleNetMember2024-06-300000766704well:OutpatientMedicalMember2024-06-300000766704well:SeniorHousingOperatingMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:SeniorHousingOperatingMember2024-01-012024-06-300000766704well:TripleNetMember2024-01-012024-06-300000766704well:OutpatientMedicalMember2024-01-012024-06-300000766704well:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:TripleNetMember2023-01-012023-06-300000766704well:OutpatientMedicalMember2023-01-012023-06-300000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-02-290000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-02-012024-02-290000766704well:SeniorsHousingRealEstatePortfolioMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:LeasesAcquiredInPlaceMember2024-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-12-310000766704us-gaap:AboveMarketLeasesMember2024-06-300000766704us-gaap:AboveMarketLeasesMember2023-12-310000766704well:LeaseCommissionsMember2024-06-300000766704well:LeaseCommissionsMember2023-12-310000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2024-04-012024-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-04-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-04-012023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-06-012023-06-300000766704well:UKPortfolioReveraJointVentureMember2023-06-300000766704well:UKPortfolioReveraJointVenture1Member2023-06-300000766704well:UKPortfolioReveraJointVenture2Member2023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-06-012023-06-300000766704well:UKPortfolioReveraJointVenture1Member2023-06-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMemberwell:AveryHealthcareMember2023-06-012023-06-300000766704well:ReveraJointVentureDisposalTransactionMember2023-06-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-07-012023-09-300000766704well:USPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraMemberwell:USPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionUSPropertiesMember2023-07-012023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2023-07-012023-09-300000766704well:ReveraJointVentureAcquisitionTransactionMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionNowWhollyOwnedPropertiesMemberwell:OakmontManagementGroupMember2023-07-012023-09-300000766704well:ReveraJointVentureDisposalTransactionExistingWhollyOwnedPropertiesMemberwell:OakmontManagementGroupMember2023-07-012023-09-300000766704well:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-300000766704well:CanadianPortfolioReveraJointVentureMember2023-09-300000766704well:ReveraJointVentureDisposalTransactionMember2024-04-012024-04-300000766704well:UKPortfolioReveraJointVenture1Member2024-04-012024-04-300000766704well:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-010000766704well:CogirSeniorLivingMemberwell:ReveraJointVentureAcquisitionTransactionMember2024-04-012024-04-010000766704well:ReveraJointVentureAcquisitionTransactionMemberwell:LevanteLivingMember2024-04-012024-04-010000766704well:ReveraJointVentureAcquisitionTransactionMemberwell:OptimaLivingMember2024-04-012024-04-010000766704well:ReveraJointVentureDisposalTransactionMember2024-04-300000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-012021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2023-03-310000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-012023-05-010000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-0100007667042023-05-012023-05-010000766704srt:MinimumMember2024-01-012024-06-300000766704srt:MaximumMember2024-01-012024-06-300000766704us-gaap:CostOfSalesMember2024-01-012024-06-300000766704us-gaap:CostOfSalesMember2023-01-012023-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMember2024-06-300000766704us-gaap:OperatingSegmentsMember2023-12-310000766704us-gaap:CorporateNonSegmentMember2023-12-310000766704us-gaap:CorporateNonSegmentMember2024-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2024-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-12-310000766704us-gaap:MortgageReceivablesMember2024-06-300000766704us-gaap:MortgageReceivablesMember2023-12-310000766704well:OtherRealEstateLoansReceivablesMember2024-06-300000766704well:OtherRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:RealEstateLoanMember2024-06-300000766704us-gaap:RealEstateLoanMember2023-12-310000766704us-gaap:RealEstateMemberus-gaap:MortgageReceivablesMember2024-06-300000766704us-gaap:RealEstateMemberus-gaap:MortgageReceivablesMember2024-01-012024-06-300000766704well:DeterioratedLoansMember2024-06-300000766704well:CollectiveLoanPool1Member2024-06-300000766704well:CollectiveLoanPool2Member2024-06-300000766704well:CollectiveLoanPool3Member2024-06-300000766704well:CollectiveLoanPool4Member2024-06-300000766704well:CollectiveLoanPool5Member2024-06-300000766704well:CollectiveLoanPool6Member2024-06-300000766704us-gaap:RealEstateLoanMember2024-06-300000766704well:SecuredAndUnsecuredDebtMemberwell:GenesisHealthCareCorporationMember2024-06-300000766704srt:MinimumMemberwell:SeniorsHousingOperatingMember2024-06-300000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2024-06-300000766704well:SeniorsHousingOperatingMember2024-06-300000766704well:SeniorsHousingOperatingMember2023-12-310000766704srt:MinimumMemberwell:TripleNetMember2024-06-300000766704well:TripleNetMembersrt:MaximumMember2024-06-300000766704well:TripleNetMember2024-06-300000766704well:TripleNetMember2023-12-310000766704srt:MinimumMemberwell:OutpatientMedicalMember2024-06-300000766704well:OutpatientMedicalMembersrt:MaximumMember2024-06-300000766704well:OutpatientMedicalMember2024-06-300000766704well:OutpatientMedicalMember2023-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-06-300000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-01-012024-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberwell:IntegraHealthcarePropertiesMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberwell:IntegraHealthcarePropertiesMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:AveryHealthcare1Memberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:AveryHealthcare1Memberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberwell:OakmontManagementGroupMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberwell:OakmontManagementGroupMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMemberwell:RemainingPortfolioMember2024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMemberwell:RemainingPortfolioMember2024-01-012024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2024-01-012024-06-300000766704well:AtriaSeniorLivingMember2024-04-012024-04-300000766704well:AtriaSeniorLivingMember2024-04-012024-06-300000766704well:AtriaSeniorLivingMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:TermCreditFacilityMember2024-06-300000766704well:TermCreditFacilityCADDenominatedMember2024-06-300000766704well:CreditFacilityTrancheDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:CreditFacilityTrancheDue2025Memberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704us-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300000766704well:AccordionfeaturememberMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:AccordionfeaturememberMemberwell:TermCreditFacilityCADDenominatedMember2024-06-300000766704us-gaap:CommercialPaperMembersrt:MaximumMember2024-01-012024-06-300000766704us-gaap:CommercialPaperMember2024-06-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000766704well:CreditFacilityTrancheDueJune2028Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDueJune2029Memberus-gaap:SubsequentEventMember2024-07-300000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-012024-07-310000766704us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704us-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:SecuredDebtMember2024-06-300000766704srt:MinimumMemberus-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2024-06-300000766704us-gaap:UnsecuredDebtMember2023-06-300000766704well:A295SeniorUnsecuredNotesDue2023Memberus-gaap:UnsecuredDebtMember2024-06-300000766704srt:MinimumMemberus-gaap:SecuredDebtMember2024-06-300000766704us-gaap:SecuredDebtMembersrt:MaximumMember2024-06-300000766704us-gaap:SecuredDebtMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2024-06-300000766704well:CanadianDealerOfferedRateMemberus-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-01-012024-06-300000766704well:CanadianDealerOfferedRateMemberus-gaap:UnsecuredDebtMemberwell:TermLoanMember2024-06-300000766704well:UkDebtDue2028Memberus-gaap:UnsecuredDebtMember2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2024-06-300000766704us-gaap:UnsecuredDebtMember2023-12-310000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-04-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-01-012024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-04-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2024-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-12-310000766704us-gaap:UnsecuredDebtMemberwell:A2029ExchangeableNotesMemberus-gaap:SubsequentEventMember2024-07-310000766704us-gaap:SecuredDebtMember2023-12-310000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2024-01-012024-06-300000766704us-gaap:SecuredDebtMember2023-01-012023-06-300000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-03-310000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-01-310000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-310000766704us-gaap:UnsecuredDebtMemberwell:A2.8SeniorUnsecuredNotesMember2024-06-300000766704us-gaap:InterestRateSwapMember2024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2024-01-012024-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-01-012023-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-12-310000766704currency:USDus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:USDus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704currency:USDus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000766704currency:USDus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000766704us-gaap:NondesignatedMemberus-gaap:ForwardContractsMembercurrency:CAD2024-06-300000766704us-gaap:NondesignatedMemberus-gaap:ForwardContractsMembercurrency:CAD2023-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2024-04-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300000766704us-gaap:NondesignatedMember2024-04-012024-06-300000766704us-gaap:NondesignatedMember2023-04-012023-06-300000766704us-gaap:NondesignatedMember2024-01-012024-06-300000766704us-gaap:NondesignatedMember2023-01-012023-06-300000766704us-gaap:WarrantMember2024-04-012024-06-300000766704us-gaap:WarrantMember2023-04-012023-06-300000766704us-gaap:WarrantMember2024-01-012024-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2024-04-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2024-01-012024-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-01-012023-06-300000766704well:SeniorsHousingOperatingPropertiesAffinityBrandMember2024-06-300000766704well:AtTheMarketProgramMember2024-04-300000766704well:AtTheMarketProgramMember2024-02-150000766704well:AtTheMarketProgramMember2024-06-300000766704well:AtTheMarketProgramMemberus-gaap:SubsequentEventMember2024-07-012024-07-300000766704well:AtTheMarketProgramMember2023-01-012023-06-300000766704well:AtTheMarketProgramMember2023-06-300000766704well:AtTheMarketProgramMember2024-01-012024-06-300000766704us-gaap:SubsequentEventMember2024-07-292024-07-290000766704us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-3100007667042022-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2024-06-300000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2023-12-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2024-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2024-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-12-310000766704us-gaap:FairValueInputsLevel1Member2024-06-300000766704us-gaap:FairValueInputsLevel2Member2024-06-300000766704us-gaap:FairValueInputsLevel3Member2024-06-300000766704us-gaap:WarrantMember2023-12-310000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2024-01-012024-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2024-06-300000766704us-gaap:WarrantMember2023-06-300000766704well:TerminalCapitalizationRateMember2024-06-300000766704well:TerminalCapitalizationRateMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-04-012024-06-300000766704us-gaap:CorporateNonSegmentMember2024-04-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2024-01-012024-06-300000766704us-gaap:CorporateNonSegmentMember2024-01-012024-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-01-012023-06-300000766704country:US2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:US2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:US2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:US2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GB2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:GB2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GB2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:GB2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CA2024-04-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:CA2023-04-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CA2024-01-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:CA2023-01-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:USus-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:USus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:USus-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:USus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:GBus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2024-04-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704country:CAus-gaap:ManagementServiceMember2023-04-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2024-01-012024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:ManagementServiceMember2024-04-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-06-300000766704us-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:ManagementServiceMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300000766704us-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:US2024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:US2024-01-012024-06-300000766704country:US2023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:US2023-01-012023-12-310000766704country:GB2024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:GB2024-01-012024-06-300000766704country:GB2023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:GB2023-01-012023-12-310000766704country:CA2024-06-300000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2024-01-012024-06-300000766704country:CA2023-12-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2024-01-012024-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-04-012024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-01-012024-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-04-012023-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-01-012023-06-30


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
or
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of July 26, 2024, Welltower Inc. had 609,147,531 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
Consolidated Statements of Comprehensive Income
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
Notes to Unaudited Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION 
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 5. Other Information
Item 6. Exhibits
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
June 30, 2024 (Unaudited)December 31, 2023 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,839,036 $4,697,824 
Buildings and improvements  38,540,623 37,796,553 
Acquired lease intangibles  2,192,386 2,166,470 
Real property held for sale, net of accumulated depreciation  81,033 372,883 
Construction in progress  1,474,024 1,304,441 
Less accumulated depreciation and amortization  (9,908,007)(9,274,814)
Net real property owned  37,219,095 37,063,357 
Right of use assets, net360,282 350,969 
Real estate loans receivable, net of credit allowance  1,791,202 1,361,587 
Net real estate investments  39,370,579 38,775,913 
Other assets:  
Investments in unconsolidated entities  1,709,558 1,636,531 
Goodwill  68,321 68,321 
Cash and cash equivalents  2,776,628 1,993,646 
Restricted cash  86,970 82,437 
Straight-line rent receivable420,666 443,800 
Receivables and other assets  1,101,215 1,011,518 
Total other assets  6,163,358 5,236,253 
Total assets  
$45,533,937 $44,012,166 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  12,169,775 13,552,222 
Secured debt  1,765,992 2,183,327 
Lease liabilities393,670 383,230 
Accrued expenses and other liabilities  1,515,921 1,521,660 
Total liabilities  
15,845,358 17,640,439 
Redeemable noncontrolling interests  
262,273 290,605 
Equity:  
Common stock  609,859 565,894 
Capital in excess of par value  36,693,283 32,741,949 
Treasury stock  (114,674)(111,578)
Cumulative net income  9,526,904 9,145,044 
Cumulative dividends  (17,492,484)(16,773,773)
Accumulated other comprehensive income (loss)  (246,462)(163,160)
Total Welltower Inc. stockholders' equity  28,976,426 25,404,376 
Noncontrolling interests  449,880 676,746 
Total equity  
29,426,306 26,081,122 
Total liabilities and equity  
$45,533,937 $44,012,166 
Note: The consolidated balance sheet at December 31, 2023 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months EndedSix Months Ended
June 30,June 30,
 2024202320242023
Revenues:  
Resident fees and services$1,393,473  $1,159,449 $2,753,747 $2,291,134 
Rental income  335,811 383,439 753,463 767,498 
Interest income63,453 38,710 116,117 75,115 
Other income32,147 83,880 61,298 92,460 
Total revenues1,824,884 1,665,478 3,684,625 3,226,207 
Expenses:
Property operating expenses1,111,297 958,672 2,208,210 1,916,425 
Depreciation and amortization382,045 341,945 747,908 681,057 
Interest expense133,424 152,337 280,742 296,740 
General and administrative expenses55,565 44,287 108,883 88,658 
Loss (gain) on derivatives and financial instruments, net(5,825)1,280 (8,879)2,210 
Loss (gain) on extinguishment of debt, net1,705 1 1,711 6 
Provision for loan losses, net5,163 2,456 6,177 3,233 
Impairment of assets2,394 1,086 45,725 13,715 
Other expenses48,684 11,069 62,815 33,814 
Total expenses1,734,452 1,513,133 3,453,292 3,035,858 
Income (loss) from continuing operations before income taxes and other items90,432 152,345 231,333 190,349 
Income tax (expense) benefit(1,101)(3,503)(7,292)(6,548)
Income (loss) from unconsolidated entities4,896 (40,332)(2,887)(47,403)
Gain (loss) on real estate dispositions, net166,443 (2,168)171,150 (1,421)
Income (loss) from continuing operations260,670 106,342 392,304 134,977 
Net income (loss)260,670 106,342 392,304 134,977 
Less: Net income (loss) attributable to noncontrolling interests(1)
5,956 3,302 10,444 6,264 
Net income (loss) attributable to common stockholders$254,714 $103,040 $381,860 $128,713 
Weighted average number of common shares outstanding:
Basic600,545 499,023 587,297 495,561 
Diluted604,563 501,970 591,047 498,305 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.43 $0.21 $0.67 $0.27 
Net income (loss) attributable to common stockholders$0.42 $0.21 $0.65 $0.26 
Diluted:
Income (loss) from continuing operations$0.43 $0.21 $0.66 $0.27 
Net income (loss) attributable to common stockholders(2)
$0.42 $0.20 $0.65 $0.26 
Dividends declared and paid per common share(3)
$0.61 $0.61 $1.22 $1.22 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.
(3) In June, the Board approved to increase the dividend to $0.67 beginning in the third quarter.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months EndedSix Months Ended
June 30,June 30,
 2024202320242023
Net income (loss)$260,670 $106,342 $392,304 $134,977 
Other comprehensive income (loss):
Foreign currency translation gain (loss)(28,340)119,519 (114,170)200,284 
Derivative and financial instruments designated as hedges gain (loss)9,096 (85,884)69,711 (155,622)
Total other comprehensive income (loss)(19,244)33,635 (44,459)44,662 
Total comprehensive income (loss)241,426 139,977 347,845 179,639 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
5,258 8,286 2,208 14,127 
Total comprehensive income (loss) attributable to common stockholders$236,168 $131,691 $345,637 $165,512 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended June 30, 2024
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2024
$565,894 $32,741,949 $(111,578)$9,145,044 $(16,773,773)$(163,160)$676,746 $26,081,122 
Comprehensive income:
Net income (loss)   127,146   4,180 131,326 
Other comprehensive income (loss)    (17,677)(6,075)(23,752)
Total comprehensive income       107,574 
Net change in noncontrolling interests (19,282)    6,191 (13,091)
Adjustment to members' interest from change in ownership in Welltower OP (18,852)    18,852  
Redemption of OP Units and DownREIT Units19 825    (844) 
Amounts related to stock incentive plans, net of forfeitures112 11,936 (3,264)    8,784 
Net proceeds from issuance of common stock26,612 2,388,521      2,415,133 
Dividends paid:
Common stock dividends    (352,529)  (352,529)
Balances at March 31, 2024
$592,637 $35,105,097 $(114,842)$9,272,190 $(17,126,302)$(180,837)$699,050 $28,246,993 
Comprehensive income:
Net income (loss)254,714 5,806 260,520 
Other comprehensive income (loss)(18,656)(95)(18,751)
Total comprehensive income241,769 
Net change in noncontrolling interests(49,943)(46,969)(256,613)(353,525)
Adjustment to members' interest from change in ownership in Welltower OP(1,833)1,833  
Redemption of OP Units and DownREIT Units476 42,636 (101)43,011 
Amounts related to stock incentive plans, net of forfeitures36 11,028 168 11,232 
Net proceeds from issuance of common stock16,710 1,586,298 1,603,008 
Dividends paid:
Common stock dividends(366,182)(366,182)
Balances at June 30, 2024
$609,859 $36,693,283 $(114,674)$9,526,904 $(17,492,484)$(246,462)$449,880 $29,426,306 


6


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
 Six Months Ended June 30, 2023
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023
$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)25,673 2,688 28,361 
Other comprehensive income (loss)8,148 3,023 11,171 
Total comprehensive income39,532 
Net change in noncontrolling interests(8,304)29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP(6,139)6,139  
Redemption of OP Units and DownREIT Units272 17,515 (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)7,540 
Net proceeds from issuance of common stock5,603 404,862 410,465 
Dividends paid:
Common stock dividends(301,829)(301,829)
Balances at March 31, 2023
$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
Comprehensive income:
Net income (loss)103,040 3,505 106,545 
Other comprehensive income (loss)28,651 4,410 33,061 
Total comprehensive income139,606 
Net change in noncontrolling interests8,579 (12,686)(149,013)(153,120)
Adjustment to members' interest from change in ownership in Welltower OP(4,794)4,794  
Redemption of OP Units and DownREIT Units1 18 (19) 
Amounts related to stock incentive plans, net of forfeitures43 11,088 893 12,024 
Net proceeds from issuance of common stock11,833 910,392 922,225 
Dividends paid:
Common stock dividends(300,772)(300,772)
Balances at June 30, 2023
$509,805 $28,085,297 $(112,032)$8,933,663 $(16,116,698)$(95,594)$619,482 $21,823,923 

7


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended
June 30,
 20242023
Operating activities:    
Net income  $392,304 $134,977 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
747,908 681,057 
Other amortization expenses  
28,106 20,086 
Provision for loan losses, net6,177 3,233 
Impairment of assets  
45,725 13,715 
Stock-based compensation expense  
22,398 19,960 
Loss (gain) on derivatives and financial instruments, net  
(8,879)2,210 
Loss (gain) on extinguishment of debt, net  
1,711 6 
Loss (income) from unconsolidated entities
2,887 47,403 
Rental income less than (in excess of) cash received  
13,696 (71,997)
Amortization related to above (below) market leases, net  
14 (248)
Loss (gain) on real estate dispositions, net  (171,150)1,421 
Proceeds from (payments on) interest rate swap settlements(59,555)(65,485)
Distributions by unconsolidated entities
10,018 6,895 
Increase (decrease) in accrued expenses and other liabilities  
53,105 (9,380)
Decrease (increase) in receivables and other assets  
(72,240)8,450 
Net cash provided from (used in) operating activities  1,012,225 792,303 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(607,527)(424,094)
Cash disbursed for capital improvements to existing properties
(297,602)(204,978)
Cash disbursed for construction in progress
(459,122)(474,115)
Capitalized interest  
(28,287)(22,205)
Investment in loans receivable
(580,145)(76,397)
Principal collected on loans receivable  
138,059 46,493 
Other investments, net of payments  
(37,185)(95,819)
Contributions to unconsolidated entities  
(146,196)(206,160)
Distributions by unconsolidated entities  
21,859 125,176 
Net proceeds from net investment hedge settlements6,631 3,933 
Proceeds from sales of real property  
129,773 1,950 
Net cash provided from (used in) investing activities  (1,859,742)(1,326,216)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
  
Net proceeds from issuance of senior unsecured notes 1,011,427 
Payments to extinguish senior unsecured notes  
(1,350,000) 
Net proceeds from the issuance of secured debt  
2,872 373,462 
Payments on secured debt  
(233,799)(101,277)
Net proceeds from the issuance of common stock  
4,020,345 1,333,908 
Payments for deferred financing costs and prepayment penalties  
(6)(6,958)
Contributions by noncontrolling interests(1)
26,569 181,272 
Distributions to noncontrolling interests(1)
(85,803)(80,672)
Cash distributions to stockholders  
(718,278)(603,597)
Other financing activities
(24,215)(5,254)
Net cash provided from (used in) financing activities  1,637,685 2,102,311 
Effect of foreign currency translation on cash and cash equivalents and restricted cash(2,653)8,379 
Increase (decrease) in cash, cash equivalents and restricted cash  787,515 1,576,777 
Cash, cash equivalents and restricted cash at beginning of period  2,076,083 722,292 
Cash, cash equivalents and restricted cash at end of period  $2,863,598 $2,299,069 
Supplemental cash flow information:
Interest paid$280,277 $273,979 
Income taxes paid (received), net9,125 1,157 
(1) Includes amounts attributable to redeemable noncontrolling interests.

8

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower Inc., a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States ("U.S."), Canada and the United Kingdom ("U.K."), consisting of seniors housing and post-acute communities and outpatient medical properties. 
We are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.737% for the six months ended June 30, 2024. As of June 30, 2024, Welltower owned 99.730% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.270% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2024 are not necessarily an indication of the results that may be expected for the year ending December 31, 2024. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.
New Accounting Standards   
In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all periods presented in the financial statements. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and disclosures.
In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09")," which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and disclosures.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs directly related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income. Our acquisition of properties are at times subject to earn out provisions based on the future operating performance of the acquired properties, which could result in incremental payments in the future. Our policy is to recognize such contingent consideration when the contingency is resolved and the consideration becomes payable.

9

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$68,662 $14,193 $10,160 $93,015 $4,426 $7,370 $60,527 $72,323 
Buildings and improvements422,488 61,914 33,064 517,466 50,172 74,289 256,190 380,651 
Acquired lease intangibles34,827  2,193 37,020 970  39,090 40,060 
Construction in progress19,397   19,397     
Right of use assets, net      927 927 
Total net real estate assets545,374 76,107 45,417 666,898 55,568 81,659 356,734 493,961 
Receivables and other assets1,403 34 112 1,549 2,089  358 2,447 
Total assets acquired546,777 76,141 45,529 668,447 57,657 81,659 357,092 496,408 
Secured debt    (21,767) (40,953)(62,720)
Lease liabilities      (953)(953)
Accrued expenses and other liabilities(11,905) (182)(12,087)(570) (8,071)(8,641)
Total liabilities acquired(11,905) (182)(12,087)(22,337) (49,977)(72,314)
Noncontrolling interests(1,149)  (1,149)    
Non-cash acquisition related activity(1)
(46,974)(710) (47,684)    
Cash disbursed for acquisitions486,749 75,431 45,347 607,527 35,320 81,659 307,115 424,094 
Construction in progress additions317,468 28 182,290 499,786 295,120 25,646 190,164 510,930 
Less: Capitalized interest(23,712) (4,575)(28,287)(16,761)(2,416)(3,028)(22,205)
Accruals (2)
474 126 (12,977)(12,377)746 (9,384)(5,972)(14,610)
Cash disbursed for construction in progress294,230 154 164,738 459,122 279,105 13,846 181,164 474,115 
Capital improvements to existing properties239,484 11,706 46,412 297,602 165,187 11,784 28,007 204,978 
Total cash invested in real property, net of cash acquired$1,020,463 $87,291 $256,497 $1,364,251 $479,612 $107,289 $516,286 $1,103,187 
(1) Primarily relates to the acquisition of assets previously financed as real estate loans receivable and the acquisition of assets previously recognized as investments in unconsolidated entities.
(2) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Announced Acquisitions
In February 2024, we entered into a definitive agreement to acquire 25 Seniors Housing Operating properties for a total purchase price of $969 million, which will be managed under the Affinity brand. The transaction is expected to close in the second half of 2024 and will be funded through a combination of cash and the expected assumption of approximately $521 million of secured debt, subject to customary closing conditions and lender consents.
In July 2024, we entered into a definitive agreement to acquire a seniors housing portfolio for approximately $0.9 billion. The transaction is expected to close later in the year, subject to customary closing conditions.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Development projects:
Seniors Housing Operating
$194,012 $140,865 
Triple-net
 141,142 
Outpatient Medical
106,596 21,173 
Total development projects
300,608 303,180 
Expansion projects
20,229 26,125 
Total construction in progress conversions$320,837 $329,305 
10

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 June 30, 2024December 31, 2023
Assets:
In place lease intangibles$2,016,507 $2,001,827 
Above market tenant leases66,663 66,663 
Lease commissions109,216 97,980 
Gross historical cost2,192,386 2,166,470 
Accumulated amortization(1,743,005)(1,651,656)
Net book value$449,381 $514,814 
Liabilities:
Below market tenant leases$70,364 $70,364 
Accumulated amortization(50,325)(47,939)
Net book value$20,039 $22,425 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Rental income related to (above)/below market tenant leases, net$(54)$130 $(85)$175 
Amortization related to in place lease intangibles and lease commissions(60,876)(53,774)(107,667)(109,925)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2024, eight Seniors Housing Operating properties and one Outpatient Medical property with an aggregate real estate balance of $81,033,000 were classified as held for sale. Expected gross sales proceeds related to these held for sale properties are approximately $95,250,000.
During the six months ended June 30, 2024, we recorded impairment charges of $41,157,000 related to nine Seniors Housing Operating properties which were disposed of or classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and $4,568,000 related to two Seniors Housing Operating properties and one Triple-net property classified as held for use for which the carrying value exceeded the estimated fair value.
During the six months ended June 30, 2023, we recorded $13,715,000 of impairment charges related to two Seniors Housing Operating properties and one Triple-net property classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell, and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value.
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of June 30, 2024 of $(9,271,000) and $(47,058,000) for the three and six months ended June 30, 2024 and $61,899,000 and $46,849,000 for the same periods in 2023, respectively.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Real estate dispositions:(1)
Seniors Housing Operating$353,290 $243,695 
Triple-net
170 2,028 
Outpatient Medical
39,567  
Total dispositions
393,027 245,723 
Gain (loss) on real estate dispositions, net171,150 (1,421)
Net other assets/(liabilities) disposed(78)(624)
 Non-cash consideration (434,326)(241,728)
Cash proceeds from real estate dispositions$129,773 $1,950 
(1) During the six months ended June 30, 2024, includes the disposition of unconsolidated equity method investments that owned six Seniors Housing Operating properties and one Outpatient Medical property.
11

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Strategic Dissolution of Revera Joint Ventures
During the quarter ended June 30, 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions included acquiring the remaining interests in 110 properties from Revera, while simultaneously selling interests in 31 properties to Revera.
In June 2023, we closed the U.K. portfolio portion of the transaction through the acquisition of the remaining ownership interest in 29 properties previously held in two separate consolidated joint venture structures in which we owned 75% and 90% of the interests in exchange for the disposition to Revera of our interests in four properties. In addition, we received cash from Revera of $107,341,000 relating to the net settlement of loans previously made to the joint ventures. Operations for the 29 retained properties were transitioned to Avery Healthcare.
Total proceeds related to the four properties disposed were $222,521,000, which included non-cash consideration from Revera of $241,728,000, comprised of the fair value of interests received by us of $198,837,000 and an allocation of Revera's noncontrolling interests of $42,891,000, partially offset by $9,049,000 of transaction-related expenses as well as the $10,158,000 of cash paid to equalize the value exchanged between the parties. We disposed of net real property owned of $224,208,000, resulting in a loss of $1,687,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 29 properties was comprised of the fair value of interests transferred by us of $198,837,000 and $5,776,000 of cash paid for transaction-related expenses. We derecognized $180,497,000 of noncontrolling interests and $22,270,000 of liabilities previously due to Revera with an adjustment of $1,846,000 recognized in capital in excess of par value.
We closed the portion of the transactions predominantly related to the U.S. portfolio during the third quarter of 2023 through (i) the acquisition of the remaining interests in ten properties currently under development or recently developed by Sunrise Senior Living that were previously held within an equity method joint venture owned 34% by us and 66% by Revera, (ii) the disposition of our minority interests in 12 U.S. properties and one Canadian development project and (iii) the disposition of our 34% interest in the Sunrise Senior Living management company. We recorded net real estate investments of $479,525,000 related to the ten acquired and now consolidated properties, which was comprised of $31,456,000 of cash consideration and $448,069,000 of non-cash consideration. Non-cash consideration primarily includes $270,486,000 of assumed mortgage debt secured by the acquired properties, which was subsequently repaid in full by us immediately following the transaction, $47,734,000 of carryover investment from our prior 34% equity method ownership interest and $119,258,000 of fair value interests in the 13 properties transferred by us to Revera. We also derecognized $56,905,000 of equity method investments related to the 13 properties retained by Revera and recorded a gain on real estate dispositions of $62,075,000. In conjunction with this transaction, operations for two of the now wholly-owned properties, along with operations for 26 existing wholly-owned properties, transitioned to Oakmont Management Group.
In April 2024, we closed the Canadian portfolio portion of the transaction through the acquisition of the remaining ownership interest in 71 properties previously held in consolidated joint venture structures in which we owned 75% of the interests, in exchange for the disposition to Revera of our interests in 14 properties. In addition, we received cash of $60,614,000 relating to the net settlement of loans previously made to Revera to fund its share of the pay-off of third party secured debt of the joint ventures. Operations for the 71 retained properties previously transitioned to Cogir Senior Living (53), Levante Living (12) and Optima Living (6) during 2023.
Total net proceeds related to the 14 properties disposed were $430,898,000, which included non-cash consideration from Revera of $434,326,000, comprised primarily of the net fair value of interests received by us of $219,940,000, debt which we were relieved of in the amount of $164,640,000 and an allocation of Revera's noncontrolling interests in the disposed properties of $53,174,000. We disposed of net real property owned of $293,257,000 and paid $3,428,000 of cash transaction-related expenses for the sale of the 14 properties, resulting in a gain of $137,641,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 71 properties was primarily comprised of the fair value of interests transferred by us of $219,940,000, a cash payment of $51,986,000 to equalize the value exchanged between the parties and $17,258,000 of cash paid for transaction-related expenses. We derecognized $246,564,000 of Revera's noncontrolling interests in the acquired properties with an adjustment of $42,619,000 recognized in capital in excess of par value.
The non-cash investing activity with respect to the sale of the properties to Revera and non-cash financing activity with respect to the acquisition of Revera's interests have been excluded from our Consolidated Statement of Cash Flows.
Genesis HealthCare
As part of the substantial exit of the Genesis HealthCare ("Genesis") operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
12

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture together with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 (excluded from the dispositions table above) after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income.
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the periods presented (in thousands):
Six Months Ended
 ClassificationJune 30, 2024June 30, 2023
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$11,830 $11,093 
Non-real estate investment lease expenseGeneral and administrative expenses3,084 3,586 
Finance lease cost:
Amortization of leased assetsProperty operating expenses2,165 3,628 
Interest on lease liabilitiesInterest expense1,747 1,980 
Sublease incomeRental income (3,933)
Total $18,826 $16,354 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationJune 30, 2024December 31, 2023
Right of use assets:
Operating leases - real estateRight of use assets, net$281,313 $283,293 
Finance leases - real estateRight of use assets, net78,969 67,676 
Real estate right of use assets, net360,282 350,969 
Operating leases - non-real estate investmentsReceivables and other assets9,660 11,338 
Total right of use assets, net$369,942 $362,307 
Lease liabilities:
Operating leases$302,309 $303,553 
Finance leases91,361 79,677 
Total$393,670 $383,230 
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. During the six months ended June 30, 2024, we wrote off previously recognized straight-line rent receivable and unamortized lease incentive balances of $97,665,000 through a reduction of rental income, which relate to leases for which the collection of substantially all contractual lease payments was no longer probable due primarily to agreements reached to convert Triple-net leased properties to Seniors Housing Operating RIDEA structures (see Note 19).
Leases in our Triple-net and Outpatient Medical portfolios recognized under ASC 842, "Leases" (ASC 842), typically include some form of operating expense reimbursement by the tenant. For the six months ended June 30, 2024, we recognized $753,463,000 of rental income related to operating leases, of which $109,607,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the six months ended June 30, 2023, we recognized $767,498,000 of rental income related to operating leases, of which $108,566,000 was for variable lease payments.
13

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $265,959,000 and $222,452,000 for the six months ended June 30, 2024 and 2023, respectively.
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets. Real estate loans receivable consists of mortgage loans and other real estate loans, which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, as well as corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $35,569,000 and $31,798,000 as of June 30, 2024 and December 31, 2023, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):
 June 30, 2024December 31, 2023
Mortgage loans$1,511,008 $1,057,516 
Other real estate loans306,399 324,660 
Allowance for credit losses on real estate loans receivable(26,205)(20,589)
Real estate loans receivable, net of credit allowance1,791,202 1,361,587 
Non-real estate loans519,513 503,993 
Allowance for credit losses on non-real estate loans receivable(171,888)(173,874)
Non-real estate loans receivable, net of credit allowance347,625 330,119 
Total loans receivable, net of credit allowance$2,138,827 $1,691,706 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Six Months Ended
 June 30, 2024June 30, 2023
Advances on loans receivable$580,145 $76,397 
Less: Receipts on loans receivable138,059 46,493 
Net cash advances (receipts) on loans receivable$442,086 $29,904 
During the six months ended June 30, 2024, we provided a first mortgage loan collateralized by a portfolio of seniors housing communities for $456,199,000. The loan bears interest at 10% per annum.
The allowance for credit losses on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality, we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.

14

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
June 30, 2024
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2023$196,211 $(169,808)$26,403 6 
Collective loan pool2010 - 2019230,146 (3,021)227,125 16 
Collective loan pool202033,415 (439)32,976 5 
Collective loan pool2021867,202 (11,566)855,636 10 
Collective loan pool2022115,338 (1,514)113,824 16 
Collective loan pool2023343,267 (4,507)338,760 13 
Collective loan pool2024551,341 (7,238)544,103 8 
Total loans$2,336,920 $(198,093)$2,138,827 74 
During the three months ended June 30, 2024, certain secured and unsecured indebtedness payable by Genesis to us, which has a carrying value of $202,434,000, was modified to extend the maturity date to June 30, 2025, with no other changes to the terms.
The total allowance for credit losses balance is deemed sufficient to absorb expected losses relating to our loan portfolio. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                            
Six Months Ended
June 30, 2024June 30, 2023
Balance at beginning of period$194,463 $164,249 
Provision for loan losses, net(1)
6,177 3,233 
Purchased deteriorated loan 19,077 
Loan write-offs(2,399) 
Foreign currency translation(148)(219)
Balance at end of period$198,093 $186,340 
(1) Excludes the provision for loan loss on held-to-maturity debt securities.
8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. Our share of the results of operations for these properties has been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 
 
Percentage Ownership (1)
June 30, 2024December 31, 2023
Seniors Housing Operating
10% to 95%
$1,334,483 $1,248,774 
Triple-net
10% to 88%
130,745 147,679 
Outpatient Medical
15% to 50%
244,330 240,078 
Total$1,709,558 $1,636,531 
(1) As of June 30, 2024 and includes ownership of investments classified as liabilities and excludes ownership of in substance real estate.
At June 30, 2024, the aggregate unamortized basis difference of our joint venture investments of $146,562,000 is primarily attributable to the difference between the amount for which we purchased our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.
We have made loans related to 24 properties as of June 30, 2024 for the development and construction of certain properties that have a carrying value of $872,746,000. We believe that such borrowers typically represent variable interest entities ("VIE" or "VIEs") in accordance with ASC 810, "Consolidation." VIEs are required to be consolidated by their primary beneficiary, which is the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. We have concluded that we are not the primary beneficiary of such borrowers, therefore, the loan arrangements were assessed based on, among other factors, the amount and timing of expected residual profits, the estimated fair value of the collateral and the significance of the borrower's equity in the project. Based on these assessments, the arrangements have been classified as in substance real estate investments. We are obligated to fund an additional $170,752,000 related to these investments.
15

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
9. Credit Concentration
We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the six months ended June 30, 2024, excluding our share of NOI in unconsolidated entities (dollars in thousands):
Concentration by relationship: (1)
Number of PropertiesTotal NOI
Percent of NOI (2)
Cogir Management Corporation105 $113,019 8%
Integra Healthcare Properties147 107,548 7%
Sunrise Senior Living88 83,943 6%
Avery Healthcare84 68,183 5%
Oakmont Management Group65 66,470 5%
Remaining portfolio1,415 1,037,252 69%
Totals1,904 $1,476,415 100%
(1) Cogir Management Corporation, Sunrise Senior Living and Oakmont Management Group are in our Seniors Housing Operating segment. Integra Healthcare Properties is in our Triple-net segment. Avery Healthcare operates assets in both our Seniors Housing Operating and Triple-net segments.
(2) NOI with our top five relationships comprised 26% of total NOI for the year ended December 31, 2023.
In April 2024, we reached an agreement to transition 89 Atria Senior Living properties to six of our existing operating partners in tranches. In conjunction with the termination of the property management agreements, we recognized $26 million within other expenses on our Consolidated Statements of Comprehensive Income during the second quarter in excess of amounts already accrued. During the three months ended June 30, 2024, we transitioned 27 properties and during July 2024 we transitioned an additional 42 properties. The remaining properties are expected to transition operations during the third quarter.
10. Borrowings Under Credit Facilities and Commercial Paper Program 
At June 30, 2024, we had a primary unsecured credit facility with a consortium of 31 banks that included a $4,000,000,000 unsecured revolving credit facility, a $1,000,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. The unsecured revolving credit facility is comprised of a $1,000,000,000 tranche that matures on June 4, 2026 (none outstanding at June 30, 2024) and a $3,000,000,000 tranche that matures on June 4, 2025 (none outstanding at June 30, 2024). The term credit facilities mature on July 19, 2026. Each tranche of the revolving facility and term loans may be extended for two successive terms of six months at our option. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $1,000,000,000 unsecured term credit facility by up to an additional $1,250,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at June 30, 2024). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over the secured overnight financing rate ("SOFR") interest rate. Based on our current credit ratings, the loans under the unsecured revolving credit facility currently bear interest at 0.775% over the adjusted SOFR rate at June 30, 2024. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at June 30, 2024
Under the terms of our commercial paper program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000 (none outstanding at June 30, 2024).
The following information relates to aggregate borrowings under the unsecured revolving credit facility and commercial paper program for the periods presented (dollars in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Balance outstanding at quarter end$$ $$
Maximum amount outstanding at any month end$$ $$205,000
Average amount outstanding (total of daily principal balances divided by days in period)$$ $$32,735
Weighted average interest rate (actual interest expense divided by average borrowings outstanding) % % %5.05 %
In July 2024, we closed on an expanded $5,000,000,000 unsecured revolving credit facility, which replaced our $4,000,000,000 existing line of credit. The new facility is comprised of a $3,000,000,000 revolving line of credit maturing in June 2028 that can be extended for an additional year and a $2,000,000,000 revolving line of credit maturing in June 2029. The revolving lines of credit will bear interest at a borrowing rate of 0.725% over the adjusted SOFR rate and includes an annual facility fee of 0.125%.
16

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
11. Senior Unsecured Notes and Secured Debt 
At June 30, 2024, the annual principal payments due on our debt obligations were as follows (in thousands):
Senior
Unsecured Notes (1,2)
Secured
Debt (3)
Totals
2024$ $106,622 $106,622 
20251,260,000 319,175 1,579,175 
2026700,000 151,137 851,137 
2027 (4,5)
1,901,929 182,536 2,084,465 
2028 (6)
2,480,200 102,640 2,582,840 
Thereafter (7)
5,982,000 938,574 6,920,574 
Total principal balance12,324,129 1,800,684 14,124,813 
Unamortized discounts and premiums, net(24,484) (24,484)
Unamortized debt issuance costs, net(65,257)(16,542)(81,799)
Fair value adjustments and other, net(64,613)(18,150)(82,763)
Total carrying value of debt$12,169,775 $1,765,992 $13,935,767 
(1) Annual interest rates range from 2.05% to 6.50%. The ending weighted average interest rate, after considering the effects of interest rate swaps, was 3.94% and 4.00% as of June 30, 2024 and June 30, 2023, respectively.
(2) All senior unsecured notes with the exception of the $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued by Welltower OP and are fully and unconditionally guaranteed by Welltower. The $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued through private placement by a wholly-owned subsidiary of Welltower OP and are fully and unconditionally guaranteed by Welltower OP.
(3) Annual interest rates range from 1.31% to 8.13%. The ending weighted average interest rate, after considering the effects of interest rate swaps and caps, was 4.64% and 4.70% as of June 30, 2024 and June 30, 2023, respectively. Gross real property value of the properties securing the debt totaled $4,966,345,000 at June 30, 2024.
(4) Includes a $1,000,000,000 unsecured term loan and a $250,000,000 Canadian-denominated unsecured term loan (approximately $182,695,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2024). Both term loans mature on July 19, 2026 and may be extended for two successive terms of six months at our option. The loans bear interest at adjusted SOFR plus 0.85% (6.28% at June 30, 2024) and adjusted Canadian Overnight Repo Rate Average plus 0.85% (5.93% at June 30, 2024), respectively.
(5) Includes a $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 (approximately $219,234,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2024).
(6) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $695,200,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on June 30, 2024).
(7) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $632,000,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on June 30, 2024).
The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):
 Six Months Ended
 June 30, 2024June 30, 2023
Beginning balance$13,699,619 $12,584,529 
Debt issued 1,035,000 
Debt extinguished(1,350,000) 
Foreign currency(25,490)75,575 
Ending balance$12,324,129 $13,695,104 
Welltower, the parent entity that consolidates Welltower OP and all other subsidiaries, fully and unconditionally guarantees to each holder of all series of senior unsecured notes issued by Welltower OP that the principal of and premium, if any, and interest on the notes will be promptly paid in full when due, whether at the applicable maturity date, by acceleration or redemption or otherwise, and interest on the overdue principal of and interest on the notes, if any, if lawful, and all other obligations of Welltower OP to the holders of the notes will be promptly paid in full or performed. Welltower's guarantees of such notes are its senior unsecured obligation and rank equally with all of Welltower's other future unsecured senior indebtedness and guarantees from time to time outstanding. Welltower's guarantees of such notes are effectively subordinated to all liabilities of its subsidiaries and to its secured indebtedness to the extent of the assets securing such indebtedness. Because Welltower conducts substantially all of its business through its subsidiaries, Welltower's ability to make required payments with respect to the guarantees depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries, whether by dividends, loans, distributions or other payments.
17

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, subject to certain contractual restrictions, at a redemption price equal to the sum of: (i) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (ii) any "make-whole" amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.
Exchangeable Senior Unsecured Notes
In May 2023, Welltower OP issued $1,035,000,000 aggregate principal amount of 2.750% exchangeable senior unsecured notes maturing May 15, 2028 (the "2028 Exchangeable Notes") unless earlier exchanged, purchased or redeemed. The 2028 Exchangeable Notes will pay interest semi-annually in arrears on May 15 and November 15 of each year. We recognized contractual interest expense on the Exchangeable Notes of approximately $7,116,000 and $14,232,000 for the three and six months ended June 30, 2024, and $3,953,000 for the same periods in 2023, respectively. Additionally, amortization of related issuance costs were $1,167,000 and $2,332,000 for the three and six ended June 30, 2024, and $693,000 for the same periods in 2023, respectively. Unamortized issuance costs were $17,958,000 as of June 30, 2024 and $20,245,000 as of December 31, 2023.
In July 2024, Welltower OP issued $1,035,000,000 aggregate principal amount of 3.125% exchangeable senior unsecured notes maturing July 15, 2029 (the "2029 Exchangeable Notes") unless earlier exchanged, purchased or redeemed. The 2029 Exchangeable Notes will pay interest semi-annually in arrears on January 15 and July 15 of each year.
The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 
 Six Months Ended
 June 30, 2024June 30, 2023
Beginning balance$2,222,445 $2,129,954 
Debt issued2,872 373,462 
Debt assumed 73,671 
Debt extinguished(211,805)(72,496)
Debt disposed(1)
(164,640) 
Principal payments(21,994)(28,781)
Foreign currency(26,194)20,781 
Ending balance$1,800,684 $2,496,591 
(1) Please see Note 5 for additional information.
Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2024, we were in compliance in all material respects with all of the covenants under our debt agreements. 
12. Derivative Instruments
We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contracts, interest rate swaps, interest rate locks and debt issued in foreign currencies to offset a portion of these risks.
Cash Flow Hedges and Fair Value Hedges of Interest Rate Risk
We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt.
Interest rate swaps designated as fair value hedges involve the receipt of fixed amounts from a counterparty in exchange for our variable-rate payments. These interest rate swap agreements hedge the exposure to changes in the fair value of fixed-rate debt attributable to changes in the designated benchmark interest rate. For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative instrument, as well as the offsetting loss or gain on the hedged item attributable to the hedged risk, are recognized in earnings. We record the gain or loss on the hedged items in interest expense,
18

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
the same line item as the offsetting loss or gain on the related interest rate swaps. In March 2022, we entered into a $550,000,000 fixed to floating swap in connection with our March 2022 senior note issuance. This swap was terminated in January 2024 resulting in a loss of $(59,555,000). As of June 30, 2024, the unamortized loss amount was $(56,489,000). In January 2024, we entered into a $550,000,000 forward-starting fixed to floating swap which converts a portion of cash flows on our $750,000,000 2.8% senior unsecured notes to floating rate. The swap is effective beginning in June 2025 and matures in December 2030. As of June 30, 2024, the carrying amount of the notes, exclusive of the hedge, is $743,143,000. The fair value of the swap as of June 30, 2024 was $(8,125,000) and was recorded as a derivative liability with an offset to senior unsecured notes on our Consolidated Balance Sheets.
Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into earnings over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately recognized in the Consolidated Statements of Comprehensive Income. Approximately $2,562,000 of losses, which are included in other comprehensive income ("OCI"), are expected to be reclassified into earnings in the next 12 months.
Cash flows from derivatives accounted for as a fair value or cash flow hedge are classified in the same category as the cash flows from the items being hedged in the Consolidated Statement of Cash Flows.
Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges
We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.
During the six months ended June 30, 2024 and 2023, we settled certain net investment hedges generating cash proceeds of $5,131,000 and $1,994,000, respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.
Derivative Contracts Undesignated
We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures.
Equity Warrants
We received equity warrants through our lending activities, which were accounted for as loan origination fees. The warrants provide us the right to participate in the capital appreciation of the underlying HC-One Group real estate portfolio above a designated price upon liquidation and contain net settlement terms qualifying as derivatives under ASC Topic 815. The warrants are classified within receivables and other assets on our Consolidated Balance Sheets. These warrants are measured at fair value with changes in fair value being recognized within loss (gain) on derivatives and financial instruments in our Consolidated Statements of Comprehensive Income.

19

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 
 June 30, 2024December 31, 2023
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$2,700,000 $2,025,000 
Denominated in Pound Sterling£1,660,708 £1,660,708 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$250,000 $250,000 
Denominated in Pound Sterling£1,050,000 £1,050,000 
Interest rate swaps and caps designated as cash flow hedges:
Denominated in U.S Dollars (1)
$522,601 $872,601 
Interest rate swaps designated as fair value hedges:
Denominated in U.S Dollars$550,000 $550,000 
Derivative instruments not designated:
Foreign currency exchange contracts denominated in Canadian Dollars$80,000 $80,000 
(1) At June 30, 2024, the maximum maturity date was September 1, 2028.
The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
DescriptionLocation2024202320242023
Gain (loss) on derivative instruments designated as hedges recognized in incomeInterest expense$5,833 $4,759 $10,651 $9,378 
Gain (loss) on derivative instruments not designated as hedges recognized in incomeInterest expense$615 $(1,175)$1,916 $(1,429)
Gain (loss) on equity warrants recognized in incomeGain (loss) on derivatives and financial instruments, net$5,825 $(1,242)$8,879 $(2,127)
Gain (loss) on derivative and financial instruments designated as hedges recognized in OCIOCI$9,096 $(85,884)$69,711 $(155,622)
13. Commitments and Contingencies
At June 30, 2024, we had 23 outstanding letter of credit obligations totaling $61,443,000 and expiring between 2024 and 2025. At June 30, 2024, we had outstanding construction in progress of $1,474,024,000 and were committed to providing additional funds of approximately $697,515,000 to complete construction. Additionally, at June 30, 2024, we had outstanding investments classified as in substance real estate of $872,746,000 and were committed to provide additional funds of $170,752,000 (see Note 8 for additional information). Purchase obligations at June 30, 2024 also include $32,002,000 of contingent purchase obligations to fund capital improvements. Rents due from the tenants are increased to reflect the additional investment in the property.
14. Stockholders' Equity 
The following is a summary of our stockholders' equity capital accounts as of the dates indicated: 
 June 30, 2024December 31, 2023
Preferred Stock, $1.00 par value:
Authorized shares50,000,000 50,000,000 
Issued shares  
Outstanding shares  
Common Stock, $1.00 par value:
Authorized shares1,400,000,000 700,000,000 
Issued shares609,933,670 566,001,632 
Outstanding shares608,150,705 564,241,181 
20

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Common Stock
In April 2024, we entered into an equity distribution agreement whereby we can offer and sell up to $3,500,000,000 aggregate amount of our common stock ("ATM Program"). Our prior equity distribution agreement dated February 15, 2024, allowing us to sell up to $3,500,000,000 aggregate amount of our common stock, was terminated as a result. The ATM Program allows us to enter into forward sale agreements (none outstanding at June 30, 2024). As of June 30, 2024, we had $2,469,193,000 of remaining capacity under the ATM Program. During July 2024, we sold 988,814 shares of common stock under our ATM Program.
The following is a summary of our common stock issuances during the six months ended June 30, 2024 and 2023 (dollars in thousands, except shares and average price amounts): 
 Shares IssuedAverage PriceGross ProceedsNet Proceeds
2023 Option exercises1,708 $63.65 $109 $109 
2023 ATM Program issuances17,435,154 76.90 1,340,727 1,333,799 
2023 Redemption of OP Units and DownREIT Units272,494 — — 
2023 Stock incentive plans, net of forfeitures(58,840)— — 
2023 Totals17,650,516 $1,340,836 $1,333,908 
2024 Option exercises
5,390 $62.34 $336 $336 
2024 ATM Program issuances
43,315,945 93.31 4,041,776 4,020,009 
2024 Redemption of OP Units and DownREIT Units
494,941 — — 
2024 Stock incentive plans, net of forfeitures
93,248 — — 
2024 Totals
43,909,524 $4,042,112 $4,020,345 
Dividends 
The following is a summary of our dividend payments (in thousands, except per share amounts): 
 Six Months Ended
 June 30, 2024June 30, 2023
Per ShareAmountPer ShareAmount
Common stock$1.22 $718,711 $1.22 $602,601 
On July 29, 2024, the Board of Directors declared a cash dividend for the quarter ended June 30, 2024 of $0.67 per share, an increase of 10% from the prior quarter.
Accumulated Other Comprehensive Income 
The following is a summary of accumulated other comprehensive income (loss) as of the dates presented (in thousands):
June 30, 2024December 31, 2023
Foreign currency translation$(1,066,688)$(913,675)
Derivative and financial instruments designated as hedges820,226 750,515 
Total accumulated other comprehensive income (loss)$(246,462)$(163,160)
15. Stock Incentive Plans
In March 2022, our Board of Directors approved the 2022 Long-Term Incentive Plan ("2022 Plan"), which authorizes up to 10,000,000 shares of common stock or units to be issued at the discretion of the Compensation Committee of the Board of Directors. Awards granted after March 28, 2022 are issued out of the 2022 Plan. The awards granted under the 2016 Long-Term Incentive Plan continue to vest and options expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2022 Plan. The 2022 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock units, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted stock units generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $10,350,000 and $22,398,000 for the three and six months ended June 30, 2024, and $10,504,000 and $19,960,000 for the same periods in 2023, respectively.
21

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
16. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Numerator for basic earnings per share - net income (loss) attributable to common stockholders
$254,714 $103,040 $381,860 $128,713 
Adjustment for net income (loss) attributable to OP Units and DownREIT Units339 (157)14 (167)
Numerator for diluted earnings per share
$255,053 $102,883 $381,874 $128,546 
Denominator for basic earnings per share - weighted average shares600,545 499,023 587,297 495,561 
Effect of dilutive securities:
Employee stock options
103 28 86 16 
Non-vested restricted shares and units1,483 1,044 1,273 882 
OP Units and DownREIT Units
2,124 1,850 2,226 1,818 
Employee stock purchase program
22 25 22 28 
2028 Exchangeable Notes286  143  
Dilutive potential common shares4,018 2,947 3,750 2,744 
Denominator for diluted earnings per share - adjusted weighted average shares
604,563 501,970 591,047 498,305 
Basic earnings per share$0.42 $0.21 $0.65 $0.26 
Diluted earnings per share$0.42 $0.20 $0.65 $0.26 
The 2028 Exchangeable Notes were not included in the computation of diluted earnings per share for the three and six months ended June 30, 2023 as they were anti-dilutive.
17. Disclosure about Fair Value of Financial Instruments 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-level valuation hierarchy exists for disclosures of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 for additional information. The three levels are defined below: 
Level 1 - Quoted prices in active markets for identical assets or liabilities. 
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.                                     
Mortgage Loans, Other Real Estate Loans and Non-real Estate Loans Receivable — The fair value of mortgage loans, other real estate loans and non-real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.
Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 
Equity Warrants The fair value of equity warrants is estimated using Level 3 inputs and includes data points such as enterprise value of the underlying HC-One Group real estate portfolio, marketability discount for private company warrants, dividend yield, volatility and risk-free rate. The enterprise value is driven by projected cash flows, weighted average cost of capital and a terminal capitalization rate.
22

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Borrowings Under Primary Unsecured Credit Facility and Commercial Paper Program — The carrying amount of the primary unsecured credit facility and commercial paper program approximates fair value because the borrowings are interest rate adjustable. 
Senior Unsecured Notes — The fair value of the senior unsecured notes payable is estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 
Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 
Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from Level 2 observable market data, including yield curves and foreign exchange rates.
Redeemable DownREIT Unitholder Interests — Our redeemable DownREIT Unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs unless the fair value is below the initial amount, in which case the redeemable DownREIT Unitholder interests are recorded at the initial amount adjusted for distributions to the unitholders and income or loss attributable to the unitholders. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
 June 30, 2024December 31, 2023
 Carrying AmountFair ValueCarrying AmountFair Value
Financial assets:
Mortgage loans receivable$1,490,989 $1,541,399 $1,043,252 $1,105,260 
Other real estate loans receivable300,213 306,204 318,335 319,905 
Cash and cash equivalents2,776,628 2,776,628 1,993,646 1,993,646 
Restricted cash86,970 86,970 82,437 82,437 
Non-real estate loans receivable347,625 330,645 330,119 312,985 
Foreign currency forward contracts, interest rate swaps and cross currency swaps46,242 46,242 37,118 37,118 
Equity warrants44,316 44,316 35,772 35,772 
Financial liabilities:
Senior unsecured notes$12,169,775 $11,811,256 $13,552,222 $13,249,247 
Secured debt1,765,992 1,723,219 2,183,327 2,144,059 
Foreign currency forward contracts, interest rate swaps and cross currency swaps17,818 17,818 96,023 96,023 
Redeemable DownREIT Unitholder interests$40,719 $40,719 $77,928 $77,928 
Items Measured at Fair Value on a Recurring Basis
The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):
 Fair Value Measurements as of June 30, 2024
 TotalLevel 1Level 2Level 3
Equity warrants$44,316 $ $ $44,316 
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
28,424  28,424  
Totals $72,740 $ $28,424 $44,316 
(1) Please see Note 12 for additional information.
23

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the change in fair value for equity warrants using unobservable Level 3 inputs for the periods presented (in thousands):
Six Months Ended
 June 30, 2024June 30, 2023
Beginning balance$35,772 $30,436 
Mark-to-market adjustment8,879 (2,126)
Foreign currency(335)1,542 
Ending balance$44,316 $29,852 
The most significant assumptions utilized in the valuation of the equity warrants are the cash flows of the underlying HC-One Group enterprise, as well as the terminal capitalization rate which was 10.0% and 11.0% at June 30, 2024 and 2023, respectively.
Items Measured at Fair Value on a Nonrecurring Basis 
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis that are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired, exchanged or assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date. 
18. Segment Reporting
We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our Seniors Housing Operating properties include seniors apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.) and combinations thereof that are generally owned and/or operated through RIDEA structures (see Note 19). Our Triple-net properties include the property types described above as well as long-term/post-acute care facilities. Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our Outpatient Medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.
We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.
Non-segment revenue consists mainly of interest income on cash investments recorded in other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. All inter-segment transactions are eliminated.
24

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 
Three Months Ended June 30, 2024Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment/CorporateTotal
Resident fees and services$1,393,473 $ $ $ $1,393,473 
Rental income 141,151 194,660  335,811 
Interest income16,077 46,528 848  63,453 
Other income1,900 931 2,577 26,739 32,147 
Total revenues1,411,450 188,610 198,085 26,739 1,824,884 
Property operating expenses1,034,906 10,495 61,185 4,711 1,111,297 
Consolidated net operating income (loss)376,544 178,115 136,900 22,028 713,587 
Depreciation and amortization253,531 61,766 66,748  382,045 
Interest expense7,326 352 1,310 124,436 133,424 
General and administrative expenses   55,565 55,565 
Loss (gain) on derivatives and financial instruments, net (5,825)  (5,825)
Loss (gain) on extinguishment of debt, net1,705    1,705 
Provision for loan losses, net6,142 (962)(17) 5,163 
Impairment of assets1,778 616   2,394 
Other expenses37,724 8,420 331 2,209 48,684 
Income (loss) from continuing operations before income taxes and other items68,338 113,748 68,528 (160,182)90,432 
Income tax (expense) benefit   (1,101)(1,101)
Income (loss) from unconsolidated entities(2,526)2,614 4,808  4,896 
Gain (loss) on real estate dispositions, net137,061 21,268 8,114  166,443 
Income (loss) from continuing operations202,873 137,630 81,450 (161,283)260,670 
Net income (loss)$202,873 $137,630 $81,450 $(161,283)$260,670 
Total assets$26,007,665 $9,454,889 $7,487,100 $2,584,283 $45,533,937 
Three Months Ended June 30, 2023Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment/CorporateTotal
Resident fees and services$1,159,449 $ $ $ $1,159,449 
Rental income 198,916 184,523  383,439 
Interest income2,095 36,520 95  38,710 
Other income2,895 66,692 1,574 12,719 83,880 
Total revenues1,164,439 302,128 186,192 12,719 1,665,478 
Property operating expenses885,187 10,598 58,697 4,190 958,672 
Consolidated net operating income (loss)279,252 291,530 127,495 8,529 706,806 
Depreciation and amortization220,428 55,234 66,283  341,945 
Interest expense16,136 (795)3,152 133,844 152,337 
General and administrative expenses   44,287 44,287 
Loss (gain) on derivatives and financial instruments, net 1,280   1,280 
Loss (gain) on extinguishment of debt, net  1  1 
Provision for loan losses, net1,867 591 (2) 2,456 
Impairment of assets 1,086   1,086 
Other expenses8,060 818 

647 1,544 11,069 
Income (loss) from continuing operations before income taxes and other items32,761 233,316 57,414 (171,146)152,345 
Income tax (expense) benefit   (3,503)(3,503)
Income (loss) from unconsolidated entities(39,445)(630)(257) (40,332)
Gain (loss) on real estate dispositions, net(2,096)(72)  (2,168)
Income (loss) from continuing operations(8,780)232,614 57,157 (174,649)106,342 
Net income (loss)$(8,780)$232,614 $57,157 $(174,649)$106,342 
25

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended June 30, 2024Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$2,753,747 $ $ $ $2,753,747 
Rental income 362,895 390,568  753,463 
Interest income21,100 93,317 1,700  116,117 
Other income3,363 2,130 4,979 50,826 61,298 
Total revenues2,778,210 458,342 397,247 50,826 3,684,625 
Property operating expenses2,054,253 21,312 123,648 8,997 2,208,210 
Consolidated net operating income (loss)723,957 437,030 273,599 41,829 1,476,415 
Depreciation and amortization490,327 124,301 133,280  747,908 
Interest expense18,512 710 3,028 258,492 280,742 
General and administrative expenses   108,883 108,883 
Loss (gain) on derivatives and financial instruments, net (8,879)  (8,879)
Loss (gain) on extinguishment of debt, net1,711    1,711 
Provision for loan losses, net7,710 (1,529)(4) 6,177 
Impairment of assets45,109 616   45,725 
Other expenses46,481 9,625 940 5,769 62,815 
Income (loss) from continuing operations before income taxes and other items114,107 312,186 136,355 (331,315)231,333 
Income tax (expense) benefit   (7,292)(7,292)
Income (loss) from unconsolidated entities(6,793)(539)4,445  (2,887)
Gain (loss) on real estate dispositions, net141,663 21,294 8,193  171,150 
Income (loss) from continuing operations248,977 332,941 148,993 (338,607)392,304 
Net income (loss)$248,977 $332,941 $148,993 $(338,607)$392,304 

Six Months Ended June 30, 2023Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$2,291,134 $ $ $ $2,291,134 
Rental income 401,335 366,163  767,498 
Interest income4,646 70,283 186  75,115 
Other income5,340 68,575 4,674 13,871 92,460 
Total revenues2,301,120 540,193 371,023 13,871 3,226,207 
Property operating expenses1,768,971 22,321 117,062 8,071 1,916,425 
Consolidated net operating income (loss)532,149 517,872 253,961 5,800 1,309,782 
Depreciation and amortization440,835 109,762 130,460  681,057 
Interest expense27,623 (810)7,256 262,671 296,740 
General and administrative expenses   88,658 88,658 
Loss (gain) on derivatives and financial
instruments, net
 2,210   2,210 
Loss (gain) on extinguishment of debt, net  6  6 
Provision for loan losses, net1,794 1,441 (2) 3,233 
Impairment of assets12,629 1,086   13,715 
Other expenses25,639 3,285 1,194 3,696 33,814 
Income (loss) from continuing operations before income taxes and other items23,629 400,898 115,047 (349,225)190,349 
Income tax (expense) benefit   (6,548)(6,548)
Income (loss) from unconsolidated entities(55,034)7,802 (171) (47,403)
Gain (loss) on real estate dispositions, net(1,263)448 (606) (1,421)
Income (loss) from continuing operations(32,668)409,148 114,270 (355,773)134,977 
Net income (loss)$(32,668)$409,148 $114,270 $(355,773)$134,977 



26

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 
 Three Months EndedSix Months Ended
 June 30, 2024June 30, 2023June 30, 2024June 30, 2023
Revenues:Amount%Amount%
Amount(1)
%Amount%
United States$1,530,174 83.9 %$1,392,512 83.7 %$3,077,070 83.5 %$2,688,534 83.3 %
United Kingdom163,264 8.9 %154,028 9.2 %324,772 8.8 %301,904 9.4 %
Canada131,446 7.2 %118,938 7.1 %282,783 7.7 %235,769 7.3 %
Total$1,824,884 100.0 %$1,665,478 100.0 %$3,684,625 100.0 %$3,226,207 100.0 %
Three Months EndedSix Months Ended
June 30, 2024June 30, 2023June 30, 2024June 30, 2023
Resident Fees and Services:Amount%Amount%
Amount(1)
%Amount%
United States$1,148,809 82.4 %$929,997 80.2 %$2,246,148 81.6 %$1,838,941 80.3 %
United Kingdom117,794 8.5 %113,585 9.8 %234,673 8.5 %222,597 9.7 %
Canada126,870 9.1 %115,867 10.0 %272,926 9.9 %229,596 10.0 %
Total$1,393,473 100.0 %$1,159,449 100.0 %$2,753,747 100.0 %$2,291,134 100.0 %
 As of
 June 30, 2024December 31, 2023
Assets:Amount%Amount%
United States$38,799,436 85.2 %$36,929,186 83.9 %
United Kingdom3,604,871 7.9 %3,587,230 8.2 %
Canada3,129,630 6.9 %3,495,750 7.9 %
Total$45,533,937 100.0 %$44,012,166 100.0 %
19. Income Taxes and Distributions 
We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 
Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA"), for taxable years beginning after July 30, 2008, a REIT may lease "qualified health care properties" on an arm's-length basis to a taxable REIT subsidiary ("TRS") if the property is operated on behalf of such TRS by a person who qualifies as an "eligible independent contractor." Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” A "qualified health care property" includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 
Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the six months ended June 30, 2024 and 2023 was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. Subsequent to 2014, we transferred certain subsidiaries to the United Kingdom, while some wholly-owned direct and indirect subsidiaries remain in Luxembourg and Jersey. We reflect current and deferred tax liabilities for any such withholding
27

WELLTOWER INC. AND SUBSIDIARIES
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
taxes incurred from this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the foreign, federal, state and local taxing authorities under applicable local laws.
The Organization for Economic Co-operation and Development has proposed a global minimum tax of 15% of reported profits ("Pillar 2") that has been agreed upon in principle by over 140 countries. During 2023, many countries incorporated Pillar 2 model rules into their laws and will continue to do so in 2024. The model rules provide a framework for applying the minimum tax and some countries have adopted Pillar 2 effective January 1, 2024; however, countries must individually enact Pillar 2 which may result in variation in the application of the model rules and timelines. We continue to evaluate the potential consequences of Pillar 2 on our longer-term financial position.
20. Variable Interest Entities 
We have entered into joint ventures and have certain subsidiaries that are either wholly owned by us or by consolidated joint ventures which own real estate investments and are deemed to be VIEs. Our VIEs primarily hold real estate assets within our Seniors Housing Operating and Triple-net portfolios, the nature and risk of which are consistent with our overall portfolio. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the entities and the rights to receive residual returns or the obligation to absorb losses arising from the entities. Except for capital contributions associated with the initial entity formations, the entities have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such entities have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):
June 30, 2024December 31, 2023
Assets:
Net real estate investments$3,277,895 $3,277,741 
Cash and cash equivalents23,158 19,529 
Receivables and other assets75,432 43,513 
Total assets (1)
$3,376,485 $3,340,783 
Liabilities and equity:
Secured debt$65,724 $76,507 
Lease liabilities2,537 2,539 
Accrued expenses and other liabilities16,893 13,850 
Total equity3,291,331 3,247,887 
Total liabilities and equity$3,376,485 $3,340,783 
(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs and the VIE's creditors do not have recourse to Welltower.
We recognized revenues from consolidated VIEs in the aggregate of $111,654,000 and $221,584,000 for the three and six months ended June 30, 2024, and $47,302,000 and $97,086,000 for the same periods in 2023, respectively.
In addition, we have certain entities that qualify as unconsolidated VIEs including borrowers of loans receivable and in substance real estate investments. Our maximum exposure on these entities is limited to the net carrying value of the investments. Refer to Note 7 and Note 8 for additional details.
28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
EXECUTIVE SUMMARY
   
Company Overview
Business Strategy
Key Transactions
 Key Performance Indicators, Trends and Uncertainties
Corporate Governance
 LIQUIDITY AND CAPITAL RESOURCES
   
Sources and Uses of Cash
Off-Balance Sheet Arrangements
Contractual Obligations
Capital Structure
Supplemental Guarantor Information
   
 RESULTS OF OPERATIONS
   
Summary
Seniors Housing Operating
Triple-net
Outpatient Medical
Non-Segment/Corporate
   
 OTHER
   
 Non-GAAP Financial Measures
 Critical Accounting Policies and Estimates
 Cautionary Statement Regarding Forward-Looking Statements
29

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read together with the Consolidated Financial Statements and related Notes thereto included in Item 1 of this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2023, including factors identified under the headings "Business," "Risk Factors," and "Management’s Discussion and Analysis of Financial Condition and Results of Operations."
We are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Welltower Inc. has no material assets or liabilities other than its investment in Welltower OP LLC. Welltower OP LLC is the borrower under, and Welltower Inc. is the guarantor of, all of the unsecured notes described in Note 11 to our unaudited consolidated financial statements.
Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP.
Executive Summary
Company Overview
Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower owns interests in properties concentrated in major, high-growth markets in the United States ("U.S."), Canada and the United Kingdom ("U.K."), consisting of seniors housing and post-acute communities and outpatient medical properties.
Welltower is the initial member and majority owner of Welltower OP, with an approximate ownership interest of 99.730% as of June 30, 2024. All of our property ownership, development and related business operations are conducted through Welltower OP and Welltower has no material assets or liabilities other than its investment in Welltower OP. Welltower issues equity from time to time, the net proceeds of which it is obligated to contribute as additional capital to Welltower OP. All debt including credit facilities, senior notes and secured debt is incurred by Welltower OP and its subsidiaries, and Welltower has fully and unconditionally guaranteed all existing senior unsecured notes.
The following table summarizes our consolidated portfolio for the three months ended June 30, 2024 (dollars in thousands):
  Percentage ofNumber of
Type of Property
NOI (1)
NOIProperties
Seniors Housing Operating$376,544 54.4 %929 
Triple-net178,115 25.8 %605 
Outpatient Medical136,900 19.8 %370 
Totals$691,559 100.0 %1,904 
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See "Non-GAAP Financial Measures" below for additional information and reconciliation.
Business Strategy
Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.
Substantially all of our revenues are derived from operating lease rentals, resident fees and services, interest earned on outstanding loans receivable and interest earned on short-term deposits. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs and market conditions among other things. We evaluate the operating environment in each
30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.
In addition to our asset management and research efforts, we aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guarantees and/or letters of credit. Also, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.
For the six months ended June 30, 2024, resident fees and services and rental income represented 75% and 20%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
Our primary sources of cash include resident fees and services, rent and interest receipts, interest earned on short-term deposits, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.
We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and commercial paper program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and commercial paper program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt. Given the general economic conditions during 2023 and into 2024, investments were generally funded proactively via issuances of common stock.
Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and commercial paper program. At June 30, 2024, we had $2,776,628,000 of cash and cash equivalents, $86,970,000 of restricted cash and $4,000,000,000 of available borrowing capacity under our unsecured revolving credit facility.
Key Transactions
Capital The following summarizes key capital transactions that occurred during the six months ended June 30, 2024:
In April 2024, we entered into the ATM Program (as defined below) pursuant to which we may offer and sell up to $3,500,000,000 of common stock of Welltower from time to time. Our prior equity distribution agreement dated February 15, 2024, allowing us to sell up to $3,500,000,000 aggregate amount of our common stock, was terminated. During the six months ended June 30, 2024, we sold 43,315,945 shares of common stock under our current and previous ATM Programs generating gross proceeds of approximately $4,041,776,000.
In January 2024, we repaid our $400,000,000 4.5% senior unsecured notes at maturity. In March 2024, we repaid our $950,000,000 3.625% senior unsecured notes at maturity.
During the six months ended June 30, 2024, we extinguished $211,805,000 of secured debt at a blended average interest rate of 6.68% and disposed $164,640,000 of secured debt at a blended average interest rate of 4.64%.
31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Investments The following summarizes our property acquisitions and joint venture investments completed during the six months ended June 30, 2024 (dollars in thousands): 
 Properties
Book Amount (1)
Capitalization Rates (2)
Seniors Housing Operating16$545,374 6.7 %
Triple-net76,107 7.7 %
Outpatient Medical45,417 7.7 %
Totals21 $666,898 6.9 %
(1) Represents amounts recorded in net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.
(2) Represents annualized contractual or projected NOI to be received in cash divided by investment amounts.
Dispositions The following summarizes property dispositions completed during the six months ended June 30, 2024 (dollars in thousands): 
 Properties
Proceeds (1)
Book Amount (2)
Capitalization Rates (3)
Seniors Housing Operating(4)
25$495,676 $353,290 4.6 %
Triple-net121,509 170 — %
Outpatient Medical(4)
346,914 39,567 6.8 %
Totals29 $564,099 $393,027 4.6 %
(1) Represents net proceeds received upon disposition.
(2) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
(3) Represents annualized contractual income that was being received in cash at date of disposition divided by stated purchase price.
(4) Includes the disposition of unconsolidated equity method investments that owned six Seniors Housing Operating properties and one Outpatient Medical property.
Strategic Dissolution of Revera Joint Ventures
During the second quarter of 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions included acquiring the remaining interests in 110 properties from Revera while simultaneously selling interests in 31 properties to Revera. See Note 5 to our unaudited consolidated financial statements for additional information regarding the transactions.
Dividends Our Board of Directors declared a cash dividend for the quarter ended June 30, 2024 of $0.67 per share, an increase of 10% from the prior quarter. On August 21, 2024, we will pay our 213th consecutive quarterly cash dividend to stockholders of record on August 12, 2024.
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, credit strength and concentration risk. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
Operating Performance We believe that net income and net income attributable to common stockholders ("NICS") per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders ("FFO") and consolidated net operating income ("NOI"); however, these supplemental measures are not defined by U.S. GAAP. Please refer to the section entitled "Non-GAAP Financial Measures" for further discussion and reconciliations. These earnings measures are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies.
The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands):
32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
 202420242023202320232023
Net income (loss)$260,670 $131,634 $88,440 $134,722 $106,342 $28,635 
NICS254,714 127,146 83,911 127,470 103,040 25,673 
FFO493,773 556,703 491,859 419,124 466,182 386,062 
NOI713,587 762,828 713,697 666,740 706,806 602,976 
Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and restricted cash. The coverage ratios indicate our ability to service interest and fixed charges (interest and secured debt principal amortization). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"). Please refer to the section entitled "Non-GAAP Financial Measures" for further discussion and reconciliation of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented: 
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
 202420242023202320232023
Net debt to book capitalization ratio27%29%34%36%38%40%
Net debt to undepreciated book capitalization ratio22%24%28%29%31%32%
Net debt to enterprise value ratio15%17%21%23%25%28%
Interest coverage ratio5.59x4.29x3.79x3.88x3.81x3.44x
Fixed charge coverage ratio5.21x3.98x3.52x3.60x3.51x3.13x
Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or countries outside the United States).
The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below: 
33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
June 30,March 31,December 31,September 30,June 30,March 31,
 202420242023202320232023
Property mix:(1)
    
Seniors Housing Operating54%47%43%45%40%42%
Triple-net(2)
26%35%37%35%42%37%
Outpatient Medical20%18%20%20%18%21%
Relationship mix: (1)
 
Cogir Management Corporation8%8%6%4%3%4%
Integra Healthcare Properties8%7%8%8%8%9%
Sunrise Senior Living6%5%5%5%7%6%
Avery Healthcare5%5%5%4%3%3%
Oakmont Management Group5%4%4%4%3%3%
Remaining relationships68%71%72%75%76%75%
Geographic mix:(1)
 
California13%11%11%11%11%13%
United Kingdom10%10%9%9%8%10%
Florida9%8%8%5%4%5%
Texas9%8%8%8%7%8%
Canada7%7%7%6%5%6%
Remaining geographic areas52%56%57%61%65%58%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) During the three months ended June 30, 2024, we wrote off previously recognized straight-line rent receivable and unamortized lease incentive balances of $88,319,000 through a reduction of rental income, which relates to leases for which the collection of substantially all contractual lease payments was no longer probable due to agreements reached to convert Triple-net properties to Seniors Housing Operating RIDEA structures.
Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of June 30, 2024 (dollars in thousands):
 
Expiration Year (1)
 2024202520262027202820292030203120322033Thereafter
Triple-net:          
Properties16 10 34 127 42 345 
Base rent (2)
$13,495 $8,016 $12,467 $1,259 $6,404 $1,051 $40,930 $11,002 $102,099 $55,517 $463,577 
% of base rent1.9 %1.1 %1.7 %0.2 %0.9 %0.1 %5.7 %1.5 %14.3 %7.8 %64.8 %
Units/beds692 521 1,557 80 616 257 3,669 423 6,163 3,267 39,443 
% of units/beds1.2 %0.9 %2.7 %0.1 %1.1 %0.5 %6.5 %0.7 %10.9 %5.8 %69.6 %
Outpatient Medical:          
Square feet1,397,5761,168,7081,540,4351,566,8251,611,3431,508,7621,327,6921,542,9361,606,9951,215,5205,018,944
Base rent (2)
$41,702$36,467$42,635$46,776$45,699$44,174$39,624$44,562$49,018$32,006$146,951
% of base rent7.3 %6.4 %7.5 %8.2 %8.0 %7.8 %7.0 %7.8 %8.6 %5.6 %25.8 %
Leases309 260 254 250 278 188 119 93 163 105 182 
% of leases14.0 %11.8 %11.5 %11.4 %12.6 %8.5 %5.4 %4.2 %7.4 %4.8 %8.4 %
(1) Excludes our share of investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved, and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in "Cautionary Statement Regarding Forward-Looking Statements" and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our
34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Annual Report on Form 10-K for the year ended December 31, 2023, under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations."
Corporate Governance
Maintaining investor confidence and trust is important in today's business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.
Liquidity and Capital Resources
Sources and Uses of Cash
Our primary sources of cash include resident fees and services, rent and interest receipts, interest earned on short-term deposits, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. 
The following is a summary of our sources and uses of cash flows for the periods presented (dollars in thousands):
 Six Months EndedChange
June 30, 2024June 30, 2023$%
Cash, cash equivalents and restricted cash at beginning of period$2,076,083 $722,292 $1,353,791 187 %
Cash provided from (used in) operating activities1,012,225 792,303 219,922 28 %
Cash provided from (used in) investing activities(1,859,742)(1,326,216)(533,526)(40)%
Cash provided from (used in) financing activities1,637,685 2,102,311 (464,626)(22)%
Effect of foreign currency translation(2,653)8,379 (11,032)(132)%
Cash, cash equivalents and restricted cash at end of period$2,863,598 $2,299,069 $564,529 25 %
Operating Activities Please see "Results of Operations" for discussion of net income fluctuations. For the six months ended June 30, 2024 and 2023, cash flows provided from operations exceeded cash distributions to stockholders. 
Investing Activities The changes in net cash provided from/used in investing activities are primarily attributable to net changes in real property investments and dispositions, loans receivable and investments in unconsolidated entities, which are summarized above in "Key Transactions." Please refer to Notes 3 and 5 of our unaudited consolidated financial statements for additional information. The following is a summary of cash used in non-acquisition capital improvement activities for the periods presented (dollars in thousands): 
 Six Months EndedChange
 June 30, 2024June 30, 2023$%
New development$459,122 $474,115 $(14,993)-3 %
Recurring capital expenditures, tenant improvements and lease commissions118,964 77,608 41,356 53 %
Renovations, redevelopments and other capital improvements178,638 127,370 51,268 40 %
Total$756,724 $679,093 $77,631 11 %
The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization. The increase in renovations, redevelopments and other capital improvements is due primarily to portfolio growth. 
Financing Activities The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuances of common stock and dividend payments which are summarized above in "Key Transactions." Please refer to Notes 10, 11 and 14 to our unaudited consolidated financial statements for additional information.
35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
In May 2023, we issued $1,035,000,000 aggregate principal amount of 2.75% exchangeable senior unsecured notes maturing May 15, 2028. In January 2024, we repaid our $400,000,000 4.5% senior unsecured notes at maturity. In March 2024, we repaid our $950,000,000 3.625% senior unsecured notes at maturity.
In July 2024, we issued $1,035,000,000 aggregate principal amount of 3.125% exchangeable senior unsecured notes maturing July 15, 2029.
Also in July 2024, we closed on an expanded $5,000,000,000 unsecured revolving credit facility, which replaced our $4,000,000,000 existing line of credit. The new facility is comprised of a $3,000,000,000 revolving line of credit maturing in June 2028 that can be extended for an additional year and a $2,000,000,000 revolving line of credit maturing in June 2029. The revolving lines of credit will bear interest at a borrowing rate of 0.725% over the adjusted SOFR rate and includes an annual facility fee of 0.125%.
Off-Balance Sheet Arrangements 
At June 30, 2024, we had investments in unconsolidated entities with our ownership generally ranging from 10% to 95%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At June 30, 2024, we had 23 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.
Contractual Obligations
The following table summarizes our payment requirements under contractual obligations as of June 30, 2024 (in thousands):
 Payments Due by Period
Contractual ObligationsTotal20242025-20262027-2028Thereafter
Senior unsecured notes and term credit facilities: (1)
U.S. Dollar senior unsecured notes$9,585,000 $— $1,950,000 $2,285,000 $5,350,000 
Canadian Dollar senior unsecured notes (2)
219,234 — — 219,234 — 
Pounds Sterling senior unsecured notes (2)
1,327,200 — — 695,200 632,000 
U.S. Dollar term credit facility1,010,000 — 10,000 1,000,000 — 
Canadian Dollar term credit facility (2)
182,695 — — 182,695 — 
Secured debt: (1,2)
Consolidated1,800,684 106,622 470,312 285,176 938,574 
Unconsolidated1,020,570 104,167 566,389 149,570 200,444 
Contractual interest obligations: (3)
Senior unsecured notes and term loans (2)
3,254,972 279,739 884,280 647,200 1,443,753 
Consolidated secured debt (2)
401,272 41,863 124,310 99,174 135,925 
Unconsolidated secured debt (2)
112,446 18,677 33,649 16,053 44,067 
Financing lease liabilities (4)
428,391 2,188 9,414 9,299 407,490 
Operating lease liabilities (4)
947,546 10,626 33,987 32,946 869,987 
Purchase obligations (5)
900,270 428,415 458,440 401 13,014 
Total contractual obligations$21,190,280 $992,297 $4,540,781 $5,621,948 $10,035,254 
(1) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Based on foreign currency exchange rates in effect as of the balance sheet date.
(3) Based on variable interest rates in effect as of the balance sheet date.
(4) See Note 6 to our unaudited consolidated financial statements for additional information.
(5) See Note 13 to our unaudited consolidated financial statements for additional information. Excludes amounts related to asset acquisitions under contract that have not yet closed as of June 30, 2024, including the acquisitions described in Note 3.
Capital Structure
Please refer to "Credit Strength" above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2024, we were in compliance in all material respects with the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest
36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
On April 1, 2022, Welltower and Welltower OP jointly filed with the Securities and Exchange Commission (the "SEC") an open-ended automatic or “universal” shelf registration statement on Form S-3 (the "Shelf Form S-3") covering an indeterminate amount of future offerings of Welltower's debt securities, common stock, preferred stock, depositary shares, guarantees of debt securities issued by Welltower OP, warrants and units and Welltower OP’s debt securities and guarantees of debt securities issued by Welltower. On April 1, 2022, Welltower also filed with the SEC a registration statement in connection with its enhanced dividend reinvestment plan ("DRIP") under which it may issue up to 15,000,000 shares of common stock. On May 3, 2023, Welltower and Welltower OP filed post-effective amendment no. 1 to the Shelf Form S-3 pursuant to which Welltower OP expressly adopted the Shelf Form S-3 as its own registration statement following its statutory conversion from a corporation to a limited liability company. As of July 26, 2024, 15,000,000 shares of common stock remained available for issuance under the DRIP registration statement.
On April 30, 2024, Welltower and Welltower OP entered into an equity distribution agreement (the "EDA") with (i) Barclays Capital Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BOK Financial Securities, Inc., Capital One Securities, Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Loop Capital Markets LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Regions Securities LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., Synovus Securities, Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as sales agents and forward sellers and (ii) the forward purchasers named therein relating to issuances, offers and sales from time to time of up to $3,500,000,000 aggregate amount of common stock of Welltower (together with the existing master forward sale confirmations relating thereto, the "ATM Program"). The ATM Program also allows Welltower to enter into forward sale agreements. As of July 26, 2024, we had $2,366,084,000 of remaining capacity under the ATM Program and there were no outstanding forward sales agreements. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and commercial paper program.
In connection with the filing of the Shelf Form S-3, Welltower also filed with the SEC a prospectus supplement that will continue an offering that was previously covered by a prior registration statement relating to the registration of up to 475,327 shares of common stock of Welltower Inc. (the "DownREIT II Shares") that may be issued from time to time if, and to the extent that, certain holders of Class A units (the "DownREIT II Units") of HCN G&L DownREIT II LLC, a Delaware limited liability company (the "DownREIT II"), tender such DownREIT II Units for redemption by the DownREIT II, and HCN DownREIT Member, LLC, a majority-owned indirect subsidiary of Welltower (including its permitted successors and assigns, the "Managing Member"), or a designated affiliate of the Managing Member, elects to assume the redemption obligations of the DownREIT II and to satisfy all or a portion of the redemption consideration by issuing DownREIT II Shares to the holders instead of or in addition to paying a cash amount. On July 22, 2022, Welltower filed with the SEC a prospectus supplement relating to the registration of up to 300,026 shares of common stock of Welltower Inc. that may be issued from time to time if, and to the extent that, certain holders of Class A Common Units (the "OP Units") of Welltower OP tender the OP Units for redemption by Welltower OP, and Welltower Inc. elects to assume the redemption obligations of Welltower OP and to satisfy all or a portion of the redemption consideration by issuing shares of its common stock to the holders instead of or in addition to paying a cash amount. On August 9, 2023, Welltower filed with the SEC a prospectus supplement relating to the registration of up to 13,559,535 shares of common stock of Welltower Inc. (the "Exchanged Shares") that may, under certain circumstances, be issuable upon exchange of 2.750% exchangeable senior notes due 2028 of Welltower OP and the resale from time to time by the recipients of the Exchanged Shares.
Supplemental Guarantor Information
Welltower OP has issued the unsecured notes described in Note 11 to our unaudited consolidated financial statements. All unsecured notes are fully and unconditionally guaranteed by Welltower, and Welltower OP is 99.730% owned by Welltower as of June 30, 2024. Effective January 4, 2021, the SEC adopted amendments to the financial disclosure requirements applicable to registered debt offerings that include certain credit enhancements. We have adopted these new rules, which permits subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. Accordingly, separate consolidated financial statements of Welltower OP have not been presented. Furthermore, Welltower and Welltower OP have no material assets, liabilities, or operations other than financing activities and their investments in non-guarantor subsidiaries. Therefore, we meet the criteria in Rule 13-01 of Regulation S-X to omit the summarized financial information from our disclosures.
37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
Summary
Our primary sources of revenue include resident fees and services, rent, interest income and interest earned on short-term deposits. Our primary expenses include property operating expenses, depreciation and amortization, interest expense, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and same store NOI ("SSNOI") and other supplemental measures include FFO and Adjusted EBITDA, which are further discussed below. Please see Non-GAAP Financial Measures for additional information and reconciliations related to these supplemental measures. 
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,
 20242023Amount%20242023Amount%
Net income (loss)$260,670 $106,342 $154,328 145 %$392,304 $134,977 $257,327 191 %
NICS254,714 103,040 151,674 147 %381,860 128,713 253,147 197 %
FFO493,773 466,182 27,591 %1,050,476 852,244 198,232 23 %
EBITDA777,240 604,127 173,113 29 %1,428,246 1,119,322 308,924 28 %
NOI713,587 706,806 6,781 %1,476,415 1,309,782 166,633 13 %
SSNOI532,202 491,584 40,618 %1,040,377 941,325 99,052 11 %
Per share data (fully diluted):    
NICS$0.42 $0.20 $0.22 110 %$0.65 $0.26 $0.39 150 %
FFO$0.82 $0.93 $(0.11)(12)%$1.78 $1.71 $0.07 %
Interest coverage ratio5.59 x3.81 x1.78 x47 %4.91 x3.63 x1.28 x35 %
Fixed charge coverage ratio5.21 x3.51 x1.70 x48 %4.57 x3.32 x1.25 x38 %

38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Seniors Housing Operating
The following is a summary of our results of operations for the Seniors Housing Operating segment (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,
 20242023$%20242023$%
Revenues:    
Resident fees and services$1,393,473 $1,159,449 $234,024 20 %$2,753,747 $2,291,134 $462,613 20 %
Interest income16,077 2,095 13,982 667 %21,100 4,646 16,454 354 %
Other income1,900 2,895 (995)(34)%3,363 5,340 (1,977)(37)%
Total revenues1,411,450 1,164,439 247,011 21 %2,778,210 2,301,120 477,090 21 %
Property operating expenses1,034,906 885,187 149,719 17 %2,054,253 1,768,971 285,282 16 %
NOI (1)
376,544 279,252 97,292 35 %723,957 532,149 191,808 36 %
Other expenses:  
Depreciation and amortization253,531 220,428 33,103 15 %490,327 440,835 49,492 11 %
Interest expense7,326 16,136 (8,810)(55)%18,512 27,623 (9,111)(33)%
Loss (gain) on extinguishment of debt, net1,705 — 1,705 n/a1,711 — 1,711 n/a
Provision for loan losses, net6,142 1,867 4,275 229 %7,710 1,794 5,916 330 %
Impairment of assets1,778 — 1,778 n/a45,109 12,629 32,480 257 %
Other expenses37,724 8,060 29,664 368 %46,481 25,639 20,842 81 %
308,206 246,491 61,715 25 %609,850 508,520 101,330 20 %
Income (loss) from continuing operations before income taxes and other items68,338 32,761 35,577 109 %114,107 23,629 90,478 383 %
Income (loss) from unconsolidated entities(2,526)(39,445)36,919 94 %(6,793)(55,034)48,241 88 %
Gain (loss) on real estate dispositions, net137,061 (2,096)139,157 n/a141,663 (1,263)142,926 n/a
Income (loss) from continuing operations202,873 (8,780)211,653 n/a248,977 (32,668)281,645 862 %
Net income (loss)202,873 (8,780)211,653 n/a248,977 (32,668)281,645 862 %
Less: Net income (loss) attributable to noncontrolling interests(442)(2,872)2,430 85 %(1,444)(6,189)4,745 77 %
Net income (loss) attributable to common stockholders$203,315 $(5,908)$209,223 n/a$250,421 $(26,479)$276,900 n/a
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Resident fees and services and property operating expenses increased for the three and six month periods ended June 30, 2024 compared to the same periods in the prior year primarily due to acquisitions outpacing dispositions during 2023 and year to date 2024. Additionally, our Seniors Housing Operating revenues are dependent on occupancy and rate growth, both of which have continued to steadily increase from prior year. Average occupancy is as follows:
Three Months Ended(1)
 March 31,June 30,September 30,December 31,
202379.0 %79.6 %80.7 %82.2 %
202482.5 %82.8 %
(1) Average occupancy includes our minority ownership share related to unconsolidated properties and excludes the minority partners' noncontrolling ownership share related to consolidated properties. Also excludes land parcels and properties under development.
Interest income increased for the three and six month periods ended June 30, 2024 compared to the same periods in the prior year primarily due to an increase in third party real estate loans in connection with the various transactions that occurred during 2023 and year to date 2024.
The following is a summary of our SSNOI at Welltower's share for the Seniors Housing Operating segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
June 30,June 30,
 20242023$%20242023$%
SSNOI (1)
$257,009 $223,244 $33,765 15.1 %$501,642 $417,923 $83,719 20.0 %
(1) For the QTD Pool and YTD Pool, amounts relate to 584 and 575 same store properties, respectively. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Depreciation and amortization fluctuates as a result of acquisitions, dispositions and transitions. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.
During the six months ended June 30, 2024, we recorded $41,157,000 of impairment charges related to nine Seniors Housing Operating properties which were disposed of or classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell. Also, we recorded $3,952,000 related to two held for use properties for which the carrying value exceeded the estimated fair value. During the six months ended June 30, 2023, we recorded impairment charges of $12,252,000 related to two held for sale properties for which the carrying values exceeded the estimated fair value less costs to sell and $377,000 related to one held for use property for which the carrying value exceeded the estimated fair value.
Transaction costs related to asset acquisitions are capitalized as a component of the purchase price. The fluctuation in other expenses is primarily due to the timing of noncapitalizable transaction costs associated with acquisitions and operator transitions, including $26 million of expense recognized during the three months ended June 30, 2024 in excess of amounts already accrued as part of the transition of 89 Atria properties to other existing Welltower operators discussed in Note 9 to our unaudited consolidated financial statements. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices. The fluctuation in the gain on sales of properties is primarily related to the disposal of the Revera Canadian portfolio, which is further discussed in Note 5 to our unaudited consolidated financial statements.
During the six months ended June 30, 2024, we completed construction conversions representing $194,012,000 or $314,444 per unit. The following is a summary of our consolidated Seniors Housing Operating construction projects in process, excluding expansions (dollars in thousands):
As of June 30, 2024
Expected Conversion Year(1)
PropertiesUnits/BedsAnticipated Remaining FundingConstruction in Progress Balance
2024131,997 $75,266 $639,908 
202582,047 240,169 365,426 
2026740 147,573 47,548 
TBD(2)
567,266 
Total30$1,120,148 
(1) Properties expected to be converted in phases over multiple years are reflected in the last expected year.
(2) Represents projects for which a final budget or expected conversion date are not yet known.
Interest expense represents secured debt interest expense, which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The provisions for loan losses will fluctuate based on our third party loan activity. The fluctuations in loss (gain) on extinguishment of debt is primarily attributable to the volume of extinguishments and terms of the related secured debt.
The following is a summary of our Seniors Housing Operating segment property secured debt principal activity (dollars in thousands):
 Three Months EndedSix Months Ended
 June 30,June 30,
2024202320242023
Beginning balance$1,804,419 $2,058,618 $1,955,048 $1,701,939 
Debt issued1,493 10,562 2,872 373,462 
Debt assumed— 20,448 — 26,930 
Debt extinguished(75,993)(3,315)(196,939)(3,315)
Debt disposed(1)
(164,640)— (164,640)— 
Principal payments(9,136)(11,997)(19,983)(25,004)
Foreign currency(5,979)20,477 (26,194)20,781 
Ending balance$1,550,164 $2,094,793 $1,550,164 $2,094,793 
Ending weighted average interest4.53 %4.71 %4.53 %4.71 %
(1) Please see Note 5 for additional information.
The majority of our Seniors Housing Operating properties are formed through partnership interests. Income (loss) from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Income (loss) from unconsolidated entities during the six months ended June 30, 2023 includes an impairment charge of $28,708,000 related to an unconsolidated management company. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures.
40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Triple-net
The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,
 20242023$%20242023$%
Revenues:    
Rental income$141,151 $198,916 $(57,765)(29)%$362,895 $401,335 $(38,440)(10)%
Interest income46,528 36,520 10,008 27 %93,317 70,283 23,034 33 %
Other income931 66,692 (65,761)(99)%2,130 68,575 (66,445)(97)%
Total revenues188,610 302,128 (113,518)(38)%458,342 540,193 (81,851)(15)%
Property operating expenses10,495 10,598 (103)(1)%21,312 22,321 (1,009)(5)%
NOI (1)
178,115 291,530 (113,415)(39)%437,030 517,872 (80,842)(16)%
Other expenses:    
Depreciation and amortization61,766 55,234 6,532 12 %124,301 109,762 14,539 13 %
Interest expense352 (795)1,147 144 %710 (810)1,520 188 %
Loss (gain) on derivatives and financial instruments, net(5,825)1,280 (7,105)(555)%(8,879)2,210 (11,089)(502)%
Provision for loan losses, net(962)591 (1,553)(263)%(1,529)1,441 (2,970)(206)%
Impairment of assets616 1,086 (470)(43)%616 1,086 (470)(43)%
Other expenses8,420 818 7,602 929 %9,625 3,285 6,340 193 %
64,367 58,214 6,153 11 %124,844 116,974 7,870 %
Income (loss) from continuing operations before income taxes and other items113,748 233,316 (119,568)(51)%312,186 400,898 (88,712)(22)%
Income (loss) from unconsolidated entities2,614 (630)3,244 515 %(539)7,802 (8,341)(107)%
Gain (loss) on real estate dispositions, net21,268 (72)21,340 n/a21,294 448 20,846 n/a
Income (loss) from continuing operations137,630 232,614 (94,984)(41)%332,941 409,148 (76,207)(19)%
Net income (loss)137,630 232,614 (94,984)(41)%332,941 409,148 (76,207)(19)%
Less: Net income (loss) attributable to noncontrolling interests5,473 6,187 (714)(12)%10,971 12,090 (1,119)(9)%
Net income attributable to common stockholders$132,157 $226,427 $(94,270)(42)%$321,970 $397,058 $(75,088)(19)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Rental income decreased primarily due to the write-off of straight-line receivable and unamortized lease incentive balances of $97,665,000 during the six months ended June 30, 2024, which relate to leases for which the collection of substantially all contractual lease payments was no longer deemed probable due primarily to agreements reached to convert Triple-net properties to Seniors Housing Operating RIDEA structures. This decrease was partially offset by increases in rent primarily due to acquisitions during the second half of 2023.
Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the six months ended June 30, 2024, we had leases with rental rate increases ranging from 0.05% to 20.05% in our Triple-net portfolio.
The increase in interest income is primarily driven by increased advances on loans receivable during the second half of 2023.
As part of the substantial exit of the Genesis HealthCare operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis HealthCare to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture together with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income during the six months ended June 30, 2023.
41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our SSNOI at Welltower's share for the Triple-net segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
June 30,June 30,
 20242023$%20242023$%
SSNOI (1)
$150,087 $144,917 $5,170 3.6 %$299,290 $287,907 $11,383 4.0 %
(1) For the QTD Pool and YTD Pool, amounts relate to 523 and 515 same store properties, respectively. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
Depreciation and amortization fluctuates as a result of the acquisitions, dispositions and segment transitions of Triple-net properties. To the extent we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 
During the six months ended June 30, 2024, we recorded an impairment charge of $616,000 related to one held for use property for which the carrying value exceeded the estimated fair value. During the six months ended June 30, 2023, we recorded impairment charges of $1,086,000 related to one held for sale property for which the carrying values exceeded the estimated fair value less costs to sell. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
Loss (gain) on derivatives and financial instruments, net is primarily attributable to the mark-to-market of the equity warrants received as part of the HC-One transactions that closed in 2021 and 2023.
Interest expense represents secured debt interest expense and related fees. The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Triple-net secured debt principal activity for the periods presented (dollars in thousands):
 Three Months EndedSix Months Ended
June 30,June 30,
 2024202320242023
Beginning balance$38,023 $38,949 $38,260 $39,179 
Principal payments(236)(226)(473)(456)
Ending balance$37,787 $38,723 $37,787 $38,723 
Ending weighted average interest4.39 %4.39 %4.39 %4.39 %
A portion of our Triple-net properties were formed through partnerships. Income (loss) from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. The fluctuation in income (loss) from unconsolidated entities from the prior year relates primarily to the timing and amount of hypothetical liquidation at book value adjustments related to in substance real estate investments. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner.
42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Outpatient Medical
The following is a summary of our results of operations for the Outpatient Medical segment for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,
 20242023$%20242023$%
Revenues:    
Rental income$194,660 $184,523 $10,137 %$390,568 $366,163 $24,405 %
Interest income848 95 753 793 %1,700 186 1,514 814 %
Other income2,577 1,574 1,003 64 %4,979 4,674 305 %
Total revenues198,085 186,192 11,893 %397,247 371,023 26,224 %
Property operating expenses61,185 58,697 2,488 %123,648 117,062 6,586 %
NOI (1)
136,900 127,495 9,405 %273,599 253,961 19,638 %
Other expenses:    
Depreciation and amortization66,748 66,283 465 %133,280 130,460 2,820 %
Interest expense1,310 3,152 (1,842)(58)%3,028 7,256 (4,228)(58)%
Loss (gain) on extinguishment of debt, net— (1)(100)%— (6)(100)%
Provision for loan losses, net(17)(2)(15)(750)%(4)(2)(2)(100)%
Other expenses331 647 (316)(49)%940 1,194 (254)(21)%
68,372 70,081 (1,709)(2)%137,244 138,914 (1,670)(1)%
Income (loss) from continuing operations before income taxes and other items68,528 57,414 11,114 19 %136,355 115,047 21,308 19 %
Income (loss) from unconsolidated entities4,808 (257)5,065 n/a4,445 (171)4,616 n/a
Gain (loss) on real estate dispositions, net8,114 — 8,114 n/a8,193 (606)8,799 n/a
Income (loss) from continuing operations81,450 57,157 24,293 43 %148,993 114,270 34,723 30 %
Net income (loss)81,450 57,157 24,293 43 %148,993 114,270 34,723 30 %
Less: Net income (loss) attributable to noncontrolling interests218 309 (91)(29)%(134)991 (1,125)(114)%
Net income (loss) attributable to common stockholders$81,232 $56,848 $24,384 43 %$149,127 $113,279 $35,848 32 %
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Rental income has increased due primarily to acquisitions and construction conversions that occurred during 2023 and year to date in 2024. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the six months ended June 30, 2024, our consolidated Outpatient Medical portfolio signed 170,090 square feet of new leases and 832,359 square feet of renewals. The weighted-average term of these leases was seven years, with a rate of $42.90 per square foot and tenant improvement and lease commission costs of $31.38 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 2.0% to 5.0%. 
The fluctuation in property operating expenses and depreciation and amortization are primarily attributable to acquisitions and construction conversions that occurred during 2023 and year to date in 2024. To the extent we acquire or dispose of additional properties in the future, these expenses will change accordingly. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
The following is a summary of our SSNOI at Welltower's share for the Outpatient Medical segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
June 30,June 30,
 20242023$%20242023$%
SSNOI (1)
$125,106 $123,423 $1,683 1.4 %$239,445 $235,495 $3,950 1.7 %
(1) For the QTD Pool and YTD, amounts relate to 410 and 380 same store properties, respectively. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the six months ended June 30, 2024, we completed construction conversions representing $106,596,000 or $484 per square foot. The following is a summary of our consolidated Outpatient Medical construction projects in process, excluding expansions (dollars in thousands):
As of June 30, 2024
Expected Conversion YearPropertiesSquare FeetAnticipated Remaining FundingConstruction in Progress Balance
20247486,763 $107,500 $203,386 
20253290,559 127,007 38,751 
TBD(1)
133,702 
Total11$275,839 
(1) Represents projects for which a final budget or expected conversion date are not yet known.
Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our Outpatient Medical secured debt principal activity (dollars in thousands):
 Three Months EndedSix Months Ended
 June 30,June 30,
2024202320242023
Beginning balance$228,334 $409,241 $229,137 $388,836 
Debt assumed— — — 46,741 
Debt extinguished(14,866)(44,550)(14,866)(69,181)
Principal payments(735)(1,616)(1,538)(3,321)
Ending balance$212,733 $363,075 $212,733 $363,075 
Ending weighted average interest5.51 %4.68 %5.51 %4.68 %
A portion of our Outpatient Medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner.
44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Non-Segment/Corporate
The following is a summary of our results of operations for the Non-Segment/Corporate activities for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,
 20242023$%20242023$%
Revenues:    
Other income$26,739 $12,719 $14,020 110 %$50,826 $13,871 $36,955 266 %
Total revenues26,739 12,719 14,020 110 %50,826 13,871 36,955 266 %
Property operating expenses4,711 4,190 521 12 %8,997 8,071 926 11 %
Consolidated net operating income (loss) (1)
22,028 8,529 13,499 158 %41,829 5,800 36,029 621 %
Expenses:   
Interest expense124,436 133,844 (9,408)(7)%258,492 262,671 (4,179)(2)%
General and administrative expenses55,565 44,287 11,278 25 %108,883 88,658 20,225 23 %
Other expenses2,209 1,544 665 43 %5,769 3,696 2,073 56 %
182,210 179,675 2,535 %373,144 355,025 18,119 %
Income (loss) from continuing operations before income taxes and other items(160,182)(171,146)10,964 %(331,315)(349,225)17,910 %
Income tax benefit (expense)(1,101)(3,503)2,402 69 %(7,292)(6,548)(744)(11)%
Income (loss) from continuing operations(161,283)(174,649)13,366 %(338,607)(355,773)17,166 %
Net income (loss)(161,283)(174,649)13,366 %(338,607)(355,773)17,166 %
Less: Net income (loss) attributable to noncontrolling interests707 (322)1,029 320 %1,051 (628)1,679 267 %
Net income (loss) attributable to common stockholders$(161,990)$(174,327)$12,337 %$(339,658)$(355,145)$15,487 %
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
The increase in other income for six month periods ended June 30, 2024 is primarily due to interest earned on deposits. Property operating expenses represent insurance costs related to our captive insurance company, which acts as a direct insurer of property level insurance coverage for our portfolio.
The following is a summary of our Non-Segment/Corporate interest expense for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,  June 30,  
 20242023$%20242023$%
Senior unsecured notes$118,212 $125,451 $(7,239)(6)%$246,172 $246,265 $(93)— %
Unsecured credit facility and commercial paper program1,533 1,467 66 %3,068 3,873 (805)(21)%
Loan expense4,691 6,926 (2,235)(32)%9,252 12,533 (3,281)(26)%
Totals$124,436 $133,844 $(9,408)(7)%$258,492 $262,671 $(4,179)(2)%
The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement in foreign exchange rates and related hedge activity. Please refer to Note 11 to our unaudited consolidated financial statements for additional information. The change in interest expense on our unsecured revolving credit facility and commercial paper program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 to our unaudited consolidated financial statements for additional information regarding our unsecured revolving credit facility and commercial paper program. Loan expenses represent the amortization of costs incurred in connection with senior unsecured notes issuances.
General and administrative expenses as a percentage of consolidated revenues for the six months ended June 30, 2024 and 2023 were 2.96% and 2.75%, respectively. The increase during the six month period is primarily driven by compensation costs associated with increased employee headcount.
45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Other
Non-GAAP Financial Measures
We believe that net income and net income attributable to common stockholders, as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts ("NAREIT") created funds from operations attributable to common stockholders ("FFO") as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.
NOI is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to managers, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent general overhead costs that are unrelated to property operations and unallocable to the properties. These expenses include, but are not limited to, payroll and benefits related to corporate employees, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI ("SSNOI") is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. We believe the drivers of property level NOI for both consolidated properties and unconsolidated properties are generally the same and therefore, we evaluate SSNOI based on our ownership interest in each property ("Welltower Share"). To arrive at Welltower's Share, NOI is adjusted by adding our minority ownership share related to unconsolidated properties and by subtracting the minority partners' noncontrolling ownership interests for consolidated properties. We do not control investments in unconsolidated properties and while we consider disclosures at Welltower Share to be useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in SSNOI five full quarters or six full quarters after acquisition or being placed into service for the QTD Pool and YTD Pool, respectively. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the respective periods are excluded from SSNOI. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties undergoing a change in intended use) are excluded from SSNOI until five full quarters or six full quarters post completion of the redevelopment for the QTD Pool and YTD Pool, respectively. Properties undergoing operator transitions and/or segment transitions are also excluded from SSNOI until five full quarters or six full quarters post completion of the transition for the QTD Pool and YTD Pool, respectively. In addition, properties significantly impacted by force majeure, acts of God, or other extraordinary adverse events are excluded from SSNOI until five full quarters or six full quarters after the properties are placed back into service for the QTD Pool and YTD Pool, respectively. SSNOI excludes non-cash NOI and includes adjustments to present consistent ownership percentages and to translate Canadian properties and U.K. properties using a consistent exchange rate. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.
EBITDA is defined as earnings (net income) before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding unconsolidated entities and including adjustments for stock-based compensation expense, provision for loan losses, gains/losses on extinguishment of debt, gains/loss/impairments on properties, gains/losses on derivatives and financial instruments, other expenses, other impairment charges and other adjustments as deemed appropriate. We believe that EBITDA and Adjusted EBITDA, along with net income, are important supplemental measures because they provide additional information to assess and evaluate the performance of our operations. We primarily use these measures to determine our interest coverage ratio, which represents EBITDA and Adjusted EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA and Adjusted EBITDA divided by fixed charges. Fixed charges include total interest and secured debt principal amortization. Covenants in our unsecured senior notes and primary credit facility contain financial ratios based on a definition of EBITDA and Adjusted EBITDA that is specific to those agreements. Our leverage ratios are defined as the proportion of net debt to total capitalization and include book capitalization, undepreciated book capitalization and enterprise value. Book capitalization represents the sum of net debt (defined as total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated

46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
depreciation and amortization. Enterprise value represents book capitalization adjusted for the fair market value of our common stock.
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
The tables below reflect the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization, gains/loss on real estate dispositions and impairment of assets. Amounts are in thousands except for per share data.
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
FFO Reconciliation:202420242023202320232023
Net income (loss) attributable to common stockholders$254,714 $127,146 $83,911 $127,470 $103,040 $25,673 
Depreciation and amortization382,045 365,863 380,730 339,314 341,945 339,112 
Impairment of assets2,394 43,331 14,994 7,388 1,086 12,629 
Loss (gain) on real estate dispositions, net(166,443)(4,707)1,783 (71,102)2,168 (747)
Noncontrolling interests(6,348)(11,996)(11,436)(8,789)(12,841)(13,327)
Unconsolidated entities27,411 37,066 21,877 24,843 30,784 22,722 
FFO$493,773 $556,703 $491,859 $419,124 $466,182 $386,062 
Average diluted shares outstanding604,563 577,530 552,380 525,138 501,970 494,494 
Per diluted share data:    
Net income attributable to common stockholders(1)
$0.42 $0.22 $0.15 $0.24 $0.20 $0.05 
FFO$0.82 $0.96 $0.89 $0.80 $0.93 $0.78 
(1) Includes adjustment to the numerator for income (loss) attributable to OP Unitholders.
 Six Months Ended
 June 30,
FFO Reconciliations:20242023
Net income attributable to common stockholders$381,860 $128,713 
Depreciation and amortization747,908 681,057 
Impairment of assets45,725 13,715 
Loss (gain) on real estate dispositions, net(171,150)1,421 
Noncontrolling interests(18,344)(26,168)
Unconsolidated entities64,477 53,506 
FFO$1,050,476 $852,244 
Average diluted common shares outstanding:591,047 498,305
Per diluted share data:  
Net income attributable to common stockholders(1)
$0.65 $0.26 
FFO$1.78 $1.71 
(1) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.
47

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The tables below reflect the reconciliation of consolidated NOI to net income, the most directly comparable U.S. GAAP measure, for the periods presented (dollars in thousands):
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
NOI Reconciliations:202420242023202320232023
Net income (loss)$260,670 $131,634 $88,440 $134,722 $106,342 $28,635 
Loss (gain) on real estate dispositions, net(166,443)(4,707)1,783 (71,102)2,168 (747)
Loss (income) from unconsolidated entities(4,896)7,783 2,008 4,031 40,332 7,071 
Income tax expense (benefit)1,101 6,191 (4,768)4,584 3,503 3,045 
Other expenses48,684 14,131 36,307 38,220 11,069 22,745 
Impairment of assets2,394 43,331 14,994 7,388 1,086 12,629 
Provision for loan losses, net5,163 1,014 2,517 4,059 2,456 777 
Loss (gain) on extinguishment of debt, net1,705 — 
Loss (gain) on derivatives and financial instruments, net(5,825)(3,054)(7,215)2,885 1,280 930 
General and administrative expenses55,565 53,318 44,327 46,106 44,287 44,371 
Depreciation and amortization382,045 365,863 380,730 339,314 341,945 339,112 
Interest expense133,424 147,318 154,574 156,532 152,337 144,403 
Consolidated net operating income (NOI)$713,587 $762,828 $713,697 $666,740 $706,806 $602,976 
NOI by segment:    
Seniors Housing Operating$376,544 $347,413 $301,077 $284,909 $279,252 $252,897 
Triple-net178,115 258,915 256,985 226,278 291,530 226,342 
Outpatient Medical136,900 136,699 135,484 129,754 127,495 126,466 
Non-segment/corporate22,028 19,801 20,151 25,799 8,529 (2,729)
Total NOI$713,587 $762,828 $713,697 $666,740 $706,806 $602,976 
 Six Months Ended
June 30,
NOI Reconciliations:20242023
Net income (loss)$392,304 $134,977 
Loss (gain) on real estate dispositions, net(171,150)1,421 
Loss (income) from unconsolidated entities2,887 47,403 
Income tax expense (benefit)7,292 6,548 
Other expenses62,815 33,814 
Impairment of assets45,725 13,715 
Provision for loan losses, net6,177 3,233 
Loss (gain) on extinguishment of debt, net1,711 
Loss (gain) on derivatives and financial instruments, net(8,879)2,210 
General and administrative expenses108,883 88,658 
Depreciation and amortization747,908 681,057 
Interest expense280,742 296,740 
Consolidated net operating income (NOI)$1,476,415 $1,309,782 
NOI by segment:
Seniors Housing Operating$723,957 $532,149 
Triple-net437,030 517,872 
Outpatient Medical273,599 253,961 
Non-segment/corporate41,829 5,800 
Total NOI$1,476,415 $1,309,782 
48

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a reconciliation of the properties included in our QTD Pool and YTD Pool for SSNOI:
QTD PoolYTD Pool
SSNOI Property Reconciliations:Seniors Housing OperatingTriple-netOutpatient MedicalTotalSeniors Housing OperatingTriple-netOutpatient MedicalTotal
Consolidated properties
929 605 370 1,904 929 605 370 1,904 
Unconsolidated properties
76 39 76 191 76 39 76 191 
Total properties
1,005 644 446 2,095 1,005 644 446 2,095 
Recent acquisitions/development conversions(1)
(80)(62)(12)(154)(89)(70)(42)(201)
Under development
(33)— (11)(44)(33)— (11)(44)
Under redevelopment(2)
(4)(4)— (8)(4)(4)— (8)
Current held for sale
(24)(28)(1)(53)(24)(28)(1)(53)
Land parcels, loans and subleases
(15)(4)(9)(28)(15)(4)(9)(28)
Transitions(3)
(256)(18)— (274)(256)(18)— (274)
Other(4)
(9)(5)(3)(17)(9)(5)(3)(17)
Same store properties
584 523 410 1,517 575 515 380 1,470 
(1) Acquisitions and development conversions will enter the QTD Pool after five full quarters and YTD Pool after six full quarters of acquisition or certificate of occupancy.
(2) Redevelopment properties will enter the QTD Pool after five full quarters and YTD Pool after six full quarters of operations post redevelopment completion.
(3) Transitioned properties will enter the QTD Pool after five full quarters and YTD Pool after six full quarters of operations with the new operator in place or under the new structure.
(4) Represents properties that are either closed or being closed.
49

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a reconciliation of our consolidated NOI to same store NOI for the periods presented for the QTD Pool and YTD Pool (dollars in thousands):
QTD PoolYTD Pool
Three Months EndedSix Months Ended
June 30,June 30,
SSNOI Reconciliations:2024202320242023
Seniors Housing Operating: 
Consolidated NOI$376,544 $279,252 $723,957 $532,149 
NOI attributable to unconsolidated investments23,041 13,629 44,822 25,756 
NOI attributable to noncontrolling interests(12,085)(15,974)(29,443)(32,235)
NOI attributable to non-same store properties(130,203)(53,574)(238,057)(108,118)
Non-cash NOI attributable to same store properties(230)(1,047)111 (1,634)
Currency and ownership adjustments (1)
(58)958 252 2,005 
SSNOI at Welltower Share257,009 223,244 501,642 417,923 
Triple-net:
Consolidated NOI178,115 291,530 437,030 517,872 
NOI attributable to unconsolidated investments5,366 6,864 10,962 16,158 
NOI attributable to noncontrolling interests(8,042)(7,723)(16,047)(15,332)
NOI attributable to non-same store properties(95,455)(122,551)(186,040)(186,663)
Non-cash NOI attributable to same store properties70,336 (23,070)53,952 (44,401)
Currency and ownership adjustments (1)
(233)(133)(567)273 
SSNOI at Welltower Share150,087 144,917 299,290 287,907 
Outpatient Medical:
Consolidated NOI136,900 127,495 273,599 253,961 
NOI attributable to unconsolidated investments4,313 4,657 9,024 9,592 
NOI attributable to noncontrolling interests(2,301)(4,708)(5,024)(9,896)
NOI attributable to non-same store properties(9,795)(1,556)(30,970)(13,553)
Non-cash NOI attributable to same store properties(4,040)(4,771)(7,247)(9,924)
Currency and ownership adjustments (1)
29 2,306 63 5,315 
SSNOI at Welltower Share125,106 123,423 239,445 235,495 
SSNOI at Welltower Share:
Seniors Housing Operating257,009 223,244 501,642 417,923 
Triple-net150,087 144,917 299,290 287,907 
Outpatient Medical125,106 123,423 239,445 235,495 
Total$532,202 $491,584 $1,040,377 $941,325 
(1) Includes adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.36 and to translate U.K. properties at a GBP/USD rate of 1.25.
50

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The tables below reflect the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented (dollars in thousands):
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
EBITDA Reconciliations:202420242023202320232023
Net income (loss)$260,670 $131,634 $88,440 $134,722 $106,342 $28,635 
Interest expense133,424 147,318 154,574 156,532 152,337 144,403 
Income tax expense (benefit)1,101 6,191 (4,768)4,584 3,503 3,045 
Depreciation and amortization382,045 365,863 380,730 339,314 341,945 339,112 
EBITDA$777,240 $651,006 $618,976 $635,152 $604,127 $515,195 
Interest Coverage Ratio:    
Interest expense$133,424 $147,318 $154,574 $156,532 $152,337 $144,403 
Capitalized interest14,478 13,809 14,547 13,947 11,870 10,335 
Non-cash interest expense(8,953)(9,284)(5,871)(6,716)(5,824)(5,083)
Total interest138,949 151,843 163,250 163,763 158,383 149,655 
EBITDA$777,240 $651,006 $618,976 $635,152 $604,127 $515,195 
Interest coverage ratio5.59 x4.29 x3.79 x3.88 x3.81 x3.44 x
Fixed Charge Coverage Ratio:    
Total interest$138,949 $151,843 $163,250 $163,763 $158,383 $149,655 
Secured debt principal payments10,107 11,887 12,430 12,865 13,839 14,942 
Total fixed charges149,056 163,730 175,680 176,628 172,222 164,597 
EBITDA$777,240 $651,006 $618,976 $635,152 $604,127 $515,195 
Fixed charge coverage ratio5.21 x3.98 x3.52 x3.60 x3.51 x3.13 x


 Six Months Ended
June 30,
EBITDA Reconciliations:20242023
Net income (loss)$392,304 $134,977 
Interest expense280,742 296,740 
Income tax expense (benefit)7,292 6,548 
Depreciation and amortization747,908 681,057 
EBITDA$1,428,246 $1,119,322 
Interest Coverage Ratio:  
Interest expense$280,742 $296,740 
Non-cash interest expense(18,237)(10,907)
Capitalized interest28,287 22,205 
Total interest290,792 308,038 
EBITDA$1,428,246 $1,119,322 
Interest coverage ratio4.91 x3.63 x
Fixed Charge Coverage Ratio:  
Total interest$290,792 $308,038 
Secured debt principal payments21,994 28,781 
Total fixed charges312,786 336,819 
EBITDA$1,428,246 $1,119,322 
Fixed charge coverage ratio4.57 x3.32 x





51

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented (dollars in thousands):
 Twelve Months Ended
June 30,March 31,December 31,September 30,June 30,March 31,
Adjusted EBITDA Reconciliations:202420242023202320232023
Net income$615,466 $461,138 $358,139 $271,497 $134,122 $123,452 
Interest expense591,848 610,761 607,846 593,663 576,813 552,226 
Income tax expense (benefit)7,108 9,510 6,364 7,044 5,717 5,279 
Depreciation and amortization1,467,952 1,427,852 1,401,101 1,362,657 1,377,042 1,345,392 
EBITDA2,682,374 2,509,261 2,373,450 2,234,861 2,093,694 2,026,349 
Loss (income) from unconsolidated entities8,926 54,154 53,442 56,084 58,751 25,477 
Stock-based compensation expense38,364 38,829 36,611 34,762 32,299 27,709 
Loss (gain) on extinguishment of debt, net1,712 94 95 697 
Loss (gain) on real estate dispositions, net(240,469)(71,858)(67,898)(65,258)4,780 6,144 
Impairment of assets68,107 66,799 36,097 34,249 31,217 30,131 
Provision for loan losses, net12,753 10,046 9,809 17,761 14,192 11,098 
Loss (gain) on derivatives and financial instruments, net(13,209)(6,104)(2,120)5,353 9,373 5,751 
Other expenses137,342 99,727 108,341 96,988 74,249 98,346 
Lease termination and leasehold interest adjustment (1)
— (65,485)(65,485)(65,485)(65,485)(56,397)
Casualty losses, net of recoveries6,163 7,778 10,107 16,446 15,760 14,865 
Other impairment (2)
114,316 25,998 16,642 12,309 — (620)
Adjusted EBITDA$2,816,379 $2,669,153 $2,509,003 $2,378,164 $2,268,925 $2,189,550 
Adjusted Interest Coverage Ratio:    
Interest expense$591,848 $610,761 $607,846 $593,663 $576,813 $552,226 
Capitalized interest56,781 54,173 50,699 45,914 40,830 35,347 
Non-cash interest expense(30,824)(27,695)(23,494)(21,903)(21,946)(22,728)
Total interest617,805 637,239 635,051 617,674 595,697 564,845 
Adjusted EBITDA$2,816,379 $2,669,153 $2,509,003 $2,378,164 $2,268,925 $2,189,550 
Adjusted interest coverage ratio4.56 x4.19 x3.95 x3.85 x3.81 x3.88 x
Adjusted Fixed Charge Coverage Ratio:
Total interest$617,805 $637,239 $635,051 $617,674 $595,697 $564,845 
Secured debt principal payments47,289 51,021 54,076 55,635 56,545 57,088 
Total fixed charges665,094 688,260 689,127 673,309 652,242 621,933 
Adjusted EBITDA$2,816,379 $2,669,153 $2,509,003 $2,378,164 $2,268,925 $2,189,550 
Adjusted fixed charge coverage ratio4.23 x3.88 x3.64 x3.53 x3.48 x3.52 x
(1) Primarily relates to the derecognition of leasehold interests and the gain recognized in other income.
(2) Represents the write-off or recovery of straight-line rent receivable and unamortized lease incentive balances relating to leases placed on cash recognition.
52

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Our leverage ratios include book capitalization, undepreciated book capitalization and enterprise value. Book capitalization represents the sum of net debt (defined as total long-term debt excluding operating lease liabilities less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Enterprise value represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization.
The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price. 
As of
 June 30,March 31,December 31,September 30,June 30,March 31,
 202420242023202320232023
Book capitalization:    
Unsecured credit facility and commercial paper$$$$$$
Long-term debt obligations (1)
14,027,12814,285,68615,815,22615,899,42016,040,53015,074,320
Cash and cash equivalents and restricted cash
(2,863,598)(2,478,335)(2,076,083)(2,686,711)(2,299,069)(638,796)
Total net debt11,163,53011,807,35113,739,14313,212,70913,741,46114,435,524
Total equity and noncontrolling interests(2)
29,688,57928,547,90826,371,72723,818,61922,193,11421,596,155
Book capitalization$40,852,109$40,355,259$40,110,870$37,031,328$35,934,575$36,031,679
Net debt to book capitalization ratio27%29%34%36%38%40%
Undepreciated book capitalization:    
Total net debt$11,163,530$11,807,351$13,739,143$13,212,709$13,741,461$14,435,524
Accumulated depreciation and amortization9,908,0079,537,5629,274,8148,868,6278,599,6228,417,151
Total equity and noncontrolling interests(2)
29,688,57928,547,90826,371,72723,818,61922,193,11421,596,155
Undepreciated book capitalization$50,760,116$49,892,821$49,385,684$45,899,955$44,534,197$44,448,830
Net debt to undepreciated book capitalization ratio22%24%28%29%31%32%
Enterprise value:    
Common shares outstanding608,151590,934564,241532,268508,159496,295
Period end share price$104.25$93.44$90.17$81.92$80.89$71.69
Common equity market capitalization$63,399,742$55,216,873$50,877,611$43,603,395$41,104,982$35,579,389
Total net debt11,163,53011,807,35113,739,14313,212,70913,741,46114,435,524
Noncontrolling interests(2)
712,153999,965967,351864,583988,6731,148,000
Consolidated enterprise value$75,275,425$68,024,189$65,584,105$57,680,687$55,835,116$51,162,913
Net debt to consolidated enterprise value ratio15%17%21%23%25%28%
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheets. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests as reflected on our Consolidated Balance Sheets.
Critical Accounting Policies and Estimates
Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
the impact of the estimates and assumptions on financial condition or operating performance is material.
Management has discussed the development and selection of its critical accounting policies and estimates with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 for further information on significant accounting policies that impact us. There have been no material changes to these policies in 2024.
53

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "pro forma," "estimate" or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause Welltower's actual results to differ materially from Welltower's expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators'/tenants' difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower's ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters, health emergencies (such as the COVID-19 pandemic) and other acts of God affecting Welltower's properties; Welltower's ability to re-lease space at similar rates as vacancies occur; Welltower's ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower's properties; changes in rules or practices governing Welltower's financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower's ability to maintain its qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower’s reports filed from time to time with the SEC. Other important factors are identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, including factors identified under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Finally, Welltower undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates. For more information, see Notes 12 and 17 to our consolidated financial statements.
We historically borrow on our unsecured revolving credit facility and commercial paper program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and commercial paper program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.
A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments after considering the effects of interest rate swaps, whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments' change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):
54

Item 3. Quantitative and Qualitative Disclosures About Market Risk
 June 30, 2024December 31, 2023
 PrincipalChange inPrincipalChange in
 balancefair valuebalancefair value
Senior unsecured notes$11,631,434 $(494,286)$12,800,253 $(515,723)
Secured debt1,436,784 (51,078)1,625,364 (58,066)
Totals$13,068,218 $(545,364)$14,425,617 $(573,789)
Our variable rate debt, including our unsecured revolving credit facility and commercial paper program, is reflected at fair value. At June 30, 2024, we had $1,056,595,000 outstanding related to our variable rate debt after considering the effects of interest rate swaps. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $10,566,000. At December 31, 2023, we had $1,496,447,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $14,964,000. 
We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or British Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended June 30, 2024, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our annualized net income from these investments would increase or decrease, as applicable, by less than $19,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or British Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments' change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):
 June 30, 2024December 31, 2023
 CarryingChange inCarryingChange in
 Valuefair valueValuefair value
Foreign currency exchange contracts$35,763 $471 $10,811 $5,087 
Debt designated as hedges1,509,895 15,099 1,527,380 15,274 
Totals$1,545,658 $15,570 $1,538,191 $20,361 
For additional information regarding fair values of financial instruments, see "Item 2 — Management's Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies" and Notes 12 and 17 to our unaudited consolidated financial statements.
Item 4. Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. No changes in our internal control over financial reporting occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

55


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition. It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.
Item 1A. Risk Factors
There have been no material changes from the risk factors identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended June 30, 2024, we acquired shares of our common stock held by employees who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from employees and the average prices paid per share for each month in the three months ended June 30, 2024 are as shown in the table below.
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Repurchase ProgramMaximum Dollar Value of Shares that May Yet Be Purchased Under the Repurchase Program
April 1, 2024 through April 30, 2024700 $90.46 — $3,000,000,000 
May 1, 2024 through May 31, 2024239 94.22 — 3,000,000,000 
June 1, 2024 through June 30, 20246,577 103.86 — 3,000,000,000 
Totals7,516 $102.31 — $3,000,000,000 
Under the terms of various partnership agreements of certain of our affiliated limited partnerships, the interest of limited partners may be redeemed, subject to certain conditions, for cash or common shares, at our option. During the three months ended June 30, 2024, we redeemed 2,199 OP Units for common shares.
On November 7, 2022, our Board of Directors approved a share repurchase program for up to $3,000,000,000 of common stock (the "Stock Repurchase Program"). Under the Stock Repurchase Program, we are not required to purchase shares but may choose to do so in the open market or through privately-negotiated transactions, through block trades, by effecting a tender offer, by way of an accelerated share repurchase program, through the purchase of call options or the sale of put options, or otherwise, or by any combination of the foregoing. We expect to finance any share repurchases using available cash and may use proceeds from borrowings or debt offerings. The Stock Repurchase Program has no expiration date and does not obligate us to repurchase any specific number of shares. We did not repurchase any shares of our common stock through the Stock Repurchase Program during the three months ended June 30, 2024.
Item 5. Other Information 
(c) Trading Plans
During the three months ended June 30, 2024, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

56


Item 6. Exhibits
3.1
3.2
4.1
10.1
10.2
10.3
Amendment No. 3 to Credit Agreement, dated as of June 14, 2024, by and among the Company; the lenders therein; KeyBank National Association, as administrative agent and L/C issuer; BofA Securities, Inc., JPMorgan Chase Bank, N.A. and Wells Fargo Securities LLC, as joint book runners; BofA Securities, as book runner; BofA Securities, Inc., JPMorgan Chase Bank, N.A., Wells Fargo Securities LLC, as U.S. joint lead arrangers; BofA Securities, Inc., JPMorgan Chase Bank, N.A., KeyBanc Capital Markets Inc. and RBC Capital Markets, as Canadian joint lead arrangers; Bank of America, N.A., JPMorgan Chase Bank, N.A. and Wells Fargo Securities LLC as co-syndication agents; Bank of America, N.A. , as syndication agent; MUFG Bank, Ltd., Barclays Bank PLC, Citibank, N.A., Credit Agricole Corporate and Investment Bank, Deutsche Bank Securities Inc., Goldman Sachs Bank USA, Mizuho Bank, Ltd., Morgan Stanley Senior Funding, Inc., PNC Bank, National Association and Royal Bank of Canada, as co-documentation agents; BNP Paribas, Citizens Bank, N.A., Fifth Third Bank, National Association, The Huntington National Bank, Regions Bank, The Bank of Nova Scotia, The Toronto-Dominion Bank, New York Branch, TD Bank, NA, Truist Bank, The Bank of New York Mellon, Banco Bilbao Vizcaya Argentaria, S.A., New York Branch and Bank of Montreal, as co-senior managing agents, Capital One, National Association, as managing agent and Credit Agricole Corporate and Investment Bank, as sustainability structuring agent.
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
104
The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, formatted in Inline XBRL
57



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the under signed thereunto duly authorized.

 
WELLTOWER INC.
  
 
Date:July 30, 2024By:  /s/ SHANKH MITRA 
 Shankh Mitra,  
 Chief Executive Officer
 (Principal Executive Officer) 
 
 
Date:July 30, 2024By:  /s/ TIMOTHY G. MCHUGH 
 Timothy G. McHugh,  
 Executive Vice President - Chief Financial Officer
 (Principal Financial Officer) 
 
 
Date:July 30, 2024By:  /s/ JOSHUA T. FIEWEGER 
 Joshua T. Fieweger,  
 Chief Accounting Officer
 (Principal Accounting Officer) 
 
58